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Intellectual! disability! (ID),! also! known! as! mental! retardation! (MR)! and! sometimes!
referred!to!as!cognitive!impairment!(Ropers!2008;!Ellison,!Rosenfeld!et!al.!2012;!Kakar,!
Goebel! et! al.! 2012;! Mefford,! Batshaw! et! al.! 2012)! is! the! most! common!
neurodevelopmental!disorder!and! is!defined!as!a! reduced!ability! to! learn,!marked!by!




as! there! is! an! international! consensus! on! the! use! of! this! term! rather! than! mental!
retardation,! although! for! the! purpose! of! literature! search! the! previous! term! would!
yield!more!results.!
ID! is! a! lifelong! disability! and! is! thought! to! affect! 103! %! of! the! general! population!
(Galasso,!Lo0Castro!et!al.!2010).! It!can!be!further!divided! into!categories!based!on! IQ!
level! (DSM0IV! classification)! that! includes,!borderline! (IQ! score!70084),!mild! (IQ! score!
50069),! moderate! (IQ! score! 35049),! severe! (IQ! score! 20034)! and! profound! (IQ! score!
below!20).!The!prevalence!of!severe!ID!is!thought!to!have!a!strong!genetic!component!
where! as! mild! to! moderate! ID! can! be! the! result! of! or! the! interaction! of! other!
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environmental! component! including! maternal! level! of! health! education! (Kaufman,!
Ayub! et! al.! 2010).! The! American! Psychiatric! Association! reported! a! 30%! higher!
incidence!of!ID!in!males!compared!to!females!in!mild!cases!(which!could!be!due!to!X0
linked!causes).!!However!in!severe!cases!the!incidence!is!thought!to!be!higher!amongst!
women.! This! is! based! on! specific! communities! and! an! overall! association! between!
gender!and!the!incidence!of!ID!is!difficult!to!establish.!Incidence!is!thought!to!be!higher!







interfere! with! normal! brain! development! including! pre0! or! postnatal! insults! such! 
as!exposure!to!toxins,!teratogens,!radiation,!alcohol,!lead,!malnutrition,!infections,!





















causative! genes! could! lead! to! the! same! phenotype,! and! over! half! of! the! genes!
identified! are! genes! involved! in! synaptic! formation,! signaling! and! plasticity.!
Understanding! the! role! of! these! genes! can! aid! in! therapeutic! intervention! at! early!
stages!or!even!in!the!enhancement!of!memory!function,!which!is!one!of!the!causative!
components! for! a! low! IQ! (Verpelli! and! Sala! 2012).! ! For! Rubinstein0Taybi! syndrome!
(RTS)!for!example,!two!potential!drug!treatments!have!been!tested!on!mouse!models!
and! they! include! suberoylanilide! hydroxamic! acid! (SAHA),! a! histone! deacetylases!
inhibitor! that! increases! the! level!of! late!phase! long! term!potentiation,!and! the!other!
drug! is!Trichostatin!A,!which! improved!memory!deficiency! in!CREBBP!transgenic!mice!
(Gropman!and!Batshaw!2010)!
Besides!structural!variation!there!are!epigenetic!factors!that!could!lead!to!deregulation!
by! gene! silencing! that! affects! transcription! (Galasso,! Lo0Castro! et! al.! 2010).! This! is!
mainly!observed!in!imprinted!disorder!where!the!methylation!pattern!that!causes!gene!
silencing! affects! the! phenotype,! and! in! the! case! of! Prader! Willi! and! Angleman!
syndrome,! the! parental! origin! of! the! same! methylated! region! leads! to! a! different!
phenotype.! ! The!majority! of! epigenetic! variations! associated!with! ID! are! thought! to!
involve! a! loss! of! function! mutations! in! single! genes.! This! suggests! a! potential!
therapeutic! benefit! through! further! understanding! of! the! affected! pathway! with!
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potential!design!of!drugs! that! can! replace! the! function!of! the!affected!gene,! such!as!















Structural! variation! is! defined! as! deletions,! duplications! (tandem! and! interspersed),!
insertions,!inversions!and!translocations!that!are!greater!than!1kb!(Malhotra!and!Sebat!
2012).!!These!are!illustrated!in!Figure 1!below.!
Genetic! variation! ranges! in! size! from!microscopically! visible! cytogenetic! aberrations,!





could! be! found! in! over! 90! X0linked! ID! forms.! This! is! in! addition! to! a! number! of!





There! seems! to! be! a! direct! correlation! between! the! size! of! the! variation! and! the!















to! chromosomal! abnormalities.! The! most! common! is! trisomy! 21! (Down! syndrome),!
! 23!
which! is! part! of! a! numerical! abnormality! mainly! resulting! in! the! presence! of! an!
additional! chromosome! 21,! accounting! for! around! two! thirds! of! cases.! ! Other! ID0
related! chromosomal! abnormalities! include!deletions,! unbalanced! translocations! and!
supernumerary! such! as! trisomies! or! monosomies.! ! However,! cytogenetically! visible!
abnormalities! through! traditional! chromosome! analysis! methods! are! limited! to! a!
resolution! of! 5! Mb.! This! restricts! the! detection! of! smaller! structural! aberrations!
pushing! for! the!use!of!alternative!methods! such!as! fluorescence! in! situ!hybridization!
(FISH),!which!has!a! resolution!of!1Mb,!and! further!advanced! techniques! that! include!











1p36! microdeletion! syndrome! (Monosomy! 1p36),! 2q23.1! microdeletion! syndrome,!
2q37! deletion! syndrome! (Williams! syndrome),! 7q11.3! microduplication! syndrome,!
15q110q13!microdeletion! syndrome! (Prader0Willi! and! Angelman! syndrome),! 16p11.2!





CNVs!are! thought! to!originate! from!two!main!pathways!either!as!a! result!of!unequal!
meiotic!recombination!or!replication!errors,!often!due!to!replication!stress!and!can!be!
induced! by! stress! agents! (Arlt,! Wilson! et! al.! 2012).! The! resulting! CNV! can! be!
categorized! into! two! main! types;! recurrent! and! non0recurrent! CNVs.! The! former!
referring! to! regions! that! are! commonly! inherited! and! of! fixed! size! while! the! latter!
refers!to!rearrangements!of!variable!size!and!breakpoints!(van!Binsbergen!2011).!
Four!mechanisms!are!believed! to! lead! to!CNV! formation!and! they! include;!nonallelic!




3,! occurs! by! the! alignment! of! low! copy! repeats! or! any!homologous!regions!and!the!
consequential!unequal!cross!over!and!recombination!that!would! lead! to! duplication! 







Non0homologous!end0joining! (NGEJ)! is!usually!a!product!of!DNA!repair!mechanism! in!
which! breaks! in! double! stranded! DNA! at! different! stages! of! enzymic! repair! activities!








The! third! mechanism! is! Fork! stalling! and! template! switching! (FoSTeS),! illustrated! 











As!a! result!of! the!1000!Genomes!project,! it!was! found! that!around!70%!of!deletions!
where! considered! to! be! the! product! of! NHEJ,! around! 90%! of! insertions! being! the!
product! of! retroposition.! Tandem! duplications! more! likely! caused! by! FoSTeS,! while!







Several! common! CNVs! have! been! curated! in! databases! available! for! public! access,!
these! include! the! Toronto! based! DGV! site! (database! of! genomic! variation)! that!




regions!overlapping!genes! linked!with! ID!but!depending!on!the! identification!method!








Some recurrent CNVs include genomic segments involving 1q21.1, 1q41-42, 
2p15-q16.1, 3q29, 7q11.23, 9q22.3, 12q14, 14q112, 15q13.3, 15q24, 16p11.2, 
16p11.2-12.2, 16p13.1, 17p11.2, 17q21.31, 19q13.11, 22q11.2. These CNVs may 
be associated with specific syndromic features. Some recurrent CNVs appear to 
be inherited and/or incompletely penetrant. In a study of 1,227 individuals using 
microarrays it was found that the burden of CNV positively correlate to severity 
of disability. A published of potentially causative CNVs have been published and 
is the subject of the next section 
(Morrow 2010; Girirajan, Brkanac et al. 2011; Girirajan, Rosenfeld et al. 2012; Grayton, 






are! mixed! in! the! cases,! nevertheless! the! large! number! of! samples! used! helped! to!






CNVs!were! found! in! 11.3%! of! cases! compared! to! 0.6%! of! controls.! In! addition,! CNV!
burden! varied! based! on! clinical! features!with!more! large! CNVs! found! in! craniofacial!
abnormalities!and!heart!defects!as!opposed!to!epilepsy!and!autism!spectrum!disorder.!





This! does! not! fall! under! the! general! umbrella! of! structural! variation! but! rather! as!
sequence! variation.! Point! mutations! or! single! base! substitutions,! that! causes! the!
replacement!of!single!nucleotide!with!another!that!disrupts!gene!expression,!has!been!
reported! in!many!studies.!These!can!be!detected!with!methods! for! single!nucleotide!
polymorphism!(SNP)!or!variation!(SNV)!and!a!number!of!these!have!been!reported!to!
cause! ID! (Rizzi,! Beunders! et! al.! 2012).!With! advances! in!next! generation! sequencing,!
more!of! these! sequence! variations! have!been! identified! and! a! replacement! that! can!
cause!malfunction!in!any!of!the!over!300!genes!associated!with!ID!would!be!considered!
pathogenic!(Rauch,!Wieczorek!et!al.!2012;!de!Ligt,!Boone!et!al.!2013).!!
To! name! a! few,! Harvey! and! colleagues! reported! sequence! variations! in! the!MECP2!
gene!in!patients!with!ID,! including!a!point!mutation!of!c.49G>A!that!causes!an!amino!
acid!change! (Harvey,!Menon!et!al.!2007)!and!point!mutations!were!reported! in!gene!








X! and! Rett! syndrome! being! the! most! common! forms! of! X0linked! ID.! Other! genes!
mutations!such!as!those!found!in!NLGN3!and!NLGN4!have!been!also!associated!with!ID!




Several! autosomal! dominant! mutations! have! been! linked! to! ID! such! as! 10! de! novo!
mutations! identified! in! genes! known! to!be!associated!with! ID!as! reported!by!de! Ligt!
and!colleagues!via!exome!sequence!analysis!of!a!cohort!of!100!patients!with!severe!ID!











by! two! copies! of! aberration! or! variation! are! required! for! the! disease! to! lead! to! a!
phenotype!under!the!classical!Mendelian!model.!!
Autosomal! recessive! ID! is! the!most! common! type!of! ID! in!populations!with! frequent!
parental! consanguinity!and! it! is! also!not!uncommon! in!outbred!Western!populations!
(Ropers!2008;!Ropers,!Derivery!et!al.!2011;!Musante!and!Ropers!2014)!!
Usually,!this!form!of!inheritance!comes!from!familial!forms!of!ID!where!parents!appear!
normal! and! the! chances! of! reoccurrence! would! be! higher! than! the! de! novo!
counterpart.! These! recessive! variant! have! been! rare! in! outbred! populations! yet!
successfully! identified! in! large! consanguineous! families! using! a! method! known! as!
homozygosity!mapping!(Kaufman,!Ayub!et!al.!2010).!!
Autozygosity!or!homozygosity!by!descent!refers!to!the!inheritance!of!the!same!variant!
from! a! common! ancestor! through! maternal! and! paternal! linages.! Children! of!




consanguineous! populations! than! outbred! ones! and! that! these! often! result! in! early!
death.!!
Homozygosity! mapping! has! been! widely! used! in! identifying! regions! that! harbor!
pathogenic! recessive! variants! due! to! the! likelihood! of! the! cosegregation! of! the!
homozygosity! region! with! the! pathogenic! variant! in! the! affected! individuals.! It! has!




As! such! a! homozygous! region! on! chromosome! 11p! have! been! identifies! in! two!
independent! studies! one! through! mapping! of! an! extended! 5! generation! Pakistani!
family!with!autosomal!recessive!severe!non0syndromic!ID!in!which!a!6MB!homozygous!
block! in! the! telomeric! region! of! 11p15! was! identified! to! cosegregate! with! the!
phenotype!(Rehman,!Baig!et!al.!2011),!while!in!a!study!of!consanguineous!Syrian!family!
a!6.4MB!homozygous!region!was!reported!amongst!ten!other!regions!and!a!mutation!






In! some!cases!of! ID! there! is! another!underpinning!mode! that! is! evident! in! its! varied!
penetrance! exemplified! by! the! heterogenous! phenotype! whereby! affected! siblings!
would! display! different! severity! of! ID.! For! these! cases! an! oligogenic! mode! of!
inheritance!is!expected!whereby!the!effect!of!a!number!of!genes!would!lead!to!disease!
manifestation! and! could! be! dosage! sensitive.! Another! suspected!model! is! that! of! a!
multifactorial!nature!whereby!early!exposure! to!environmental!agents!would! lead! to!
the!triggering!of!susceptibility!genes!or!an!epigenetic!switching!that!would!lead!to!the!








it! comes! to! heterogenous! ID! in! the! general! population! (Heil! and! Schaaf! 2013).! This!
makes! it! difficult! to! pool! samples! to! identify! a! common! cause! as! a! variable! one! is!






moderate,! severe! and! profound! IQ.! This! adds! to! the! phenotypic!mix! of! ID! and! it! is!
worth!mentioning!that!the!ID!score!is!based!on!a!multiple!component!tests!that!yield!
to! the! overall! score! such! as! tests! on! memory! and! ordering! objects.! Hence,! the!
underlying! genetic! cause! could! differ! from! case! to! case,! although! the! general!
phenotype!is!that!of!ID!differing!only!in!severity.!Conversely!phenotypic!heterogeneity!
has! been! observed! were! a! deletion! in! the! same! region! has! lead! to! a! different!
phenotype.!!
Such! is! the! case! of! chromosome! 15q13.3! deletion! that! has! been! associated! to! ID,!
schizophrenia,! autism! and! 1%! of! idiopathic! generalized! epilepsy.! These! phenotypic!
discrepancies!have!been!difficult!to!explain!and!Girirajan!and!colleagues!have!proposed!
a! “two0hit”!model! based! on! a! common! observation! where! affected! individuals! of! a!
16p12.1! chromosomal! microdeletion! have! additional! CNVs! compared! with! controls.!
This!support!the!oligogenic!mode!of!inheritance!in!which!small!number!of!rare!variants!
of!a! large!effect!causes!a!heterogeneous!genomic!disorder!(Girirajan,!Rosenfeld!et!al.!
























































































































































































































































































are! often! limited! to! few! disorders! where! there! is! research! interest! by! reputable!
universities! or! genetic! centres! abroad.! Nevertheless,! such! collaboration! takes! a! long!
process!to!set!up!and!in!the!majority!of!cases!diagnostics!is!offered!on!locally!available!
tests!or!is!reviewed!on!case!per!case!basis!on!whether!a!known!genetic!cause!has!been!
identified,! in!which!sending!samples!abroad!to!a!specialized!centre! for!a!specific! test!
would! be! reviewed! by! a! specialist! committee,! taking! into! consideration! costs! and!
number!of!test!required!as!well!as!how!informative!the!results!would!be!and!scope!of!
benefit.! For! example,! a! disorder! with! a! few! known! genes! with! multiple! affected!
members!would!be! considered! for! testing!opposed! to!a! rare!disorder!with!unknown!
genetic!cause!in!a!single!individual.!In!addition,!the!urgency!of!having!the!results!is!also!
considered,! in! cases! of! cancer! for! example,! it! would! have! an! impact! on! advised!
treatment!or!intervention.!
Within! KMGC,! the! genetic! diagnostic! testing! carried! out! on! cases! with! ID! and! or!
congenital!malformations!relies!heavily!on!cytogenetic!karyotyping!and!in!some!cases!
FISH! technique! is! then! applied! to! identify! known! chromosomal! abnormality.! On! the!
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molecular! level! only! few! tests! are! available! for! specific! syndromes! such! as! Fragile! X!
expansion,! and! it! is! automatically! offered! as! a! test! to! any! case! of! ID! cases! upon!
confirming!a!normal!karyotype,!with!around!500!cases!being!tested!per!year.!
Advances! in! the! field!have!sparked!ambitions! to!start! investing! in!new!machines!and!
techniques! that! would! further! advance! the! genetic! services! on! offer.! ! Intellectual!
disability! is! one!of! the!major!disorders! referred! to!KMGC!and! it! is! often! to!establish!
disability!and!report!that!it!is!from!birth!in!order!for!parents!to!claim!benefits!offered!
by! the! government! that! varies! depending!on! the! condition! and! severity! of! the! case,!






for! “healthy! offspring”,! in!which! the! first!wife!would! be! expected! to! accept! such! an!
arrangement.!!
In!addition,!there!is!a!high!incidence!of!first!or!even!double!cousin!marriages!and!cases!
with! a! family! history! of! ID!would! be! referred! to! the! KMGC! for! a! premarital! genetic!
counselling!session!or!for!family!planning!of!additional!pregnancies.!It!is!important!for!
any! session! to! have! an! estimated! risk! that! is! based! on! the! genetic! etiology! of! the!
disorder! and! taking! into! account! the!mode! of! inheritance! and! if! any! testing! can! be!





that! it! will! be! part! of! a! big! research! project! with! set! collaborations! such! as! autism!
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spectrum! disorders.! Remaining! cases! would! be! regarded! as! unsolved! and! families!
would!be!left!to!make!decisions!on!the!uncertain!information!given.!!Many!would!hope!







• Detect! known! and! novel! CREBBP! mutations! and! deletions! in! the! Kuwaiti!
population!by!HAT!domain!sequencing!and!copy!number!analysis.!
• Identify! novel! RTS! causing! gene(s)! in! cases! without! CREBBP!mutations,! using!
microarray! based! copy! number! variant! analysis,! and! explore! whether! these!
mutations!can!explain!other!types!of!mental!retardation.!




• Follow! up! specific! CNVs! identified! with! gene! expression! and! bioinformatic!
analysis.!












of" the" genome," which" causes" nonBCREBBP" forms" of" RTS" or" familial" mental"

















Kuwait! is! a! Middle! Eastern! country! located! in! Southwest! Asia,! sharing! borders! with!
Southern!Iraq,!Northern!Saudi!Arabia!and!the!Arabian!Gulf!on!the!East.!This!small!state!
covers!17,820!square!kilometers,!around!200!kilometers!from!north!to!south!and!170!
kilometers! across.! Kuwait! was! the! Centre! of! pearl! diving! and! boat! construction! until!












Arab! descent;! 30035%! is! Asian! (including! South! East! and! Far! east! Asians),! while! the!
remaining!5010%!consists!of!other!nationals!including!mostly!Africans,!East!Asians!and!
Europeans.!!!





Literacy! rate! is! at! a! 93%! high,! due! to! government! support! with! free! education,!






The! Kuwait!Medical! Genetic! Centre! (KMGC)! is! located! in! the! Al0Asimah! governorate!






The! former! minister! of! health! Dr! Abdul! Rahman! Al! Awadi! officially! established! the!
centre!in!1980!with!genetic!services!being!offered!in!genetic!clinics!on!weekly!basis!and!
analysis! supported! by! the! Biology! Department! in! the! Faculty! of! Science! at! Kuwait!
University.!For!molecular!testing!samples!were!sent!to!the!US!or!the!UK!with!focus!on!
genetic! disorders! including;! infertility,! cases! of! repeated! spontaneous! abortion,!
congenital! malformations,! cases! of! suspected! chromosomal! disorders,! familial! ID,!
hearing! impairment,! ophthalmological! disorders,! short! stature,! and! haematological!
diseases.!
KMGC! was! rebuilt! after! the! Iraqi! invasion! in! 1990! and! was! developed! to! contain! a!
molecular! genetics! laboratory,! fluorescence! in" situ! hybridization! (FISH)! laboratory! as!
well! as! the! cytogenetic! laboratory.! In! 2009! the! KMGC! was! moved! to! a! newly! built!
centre! near! the! old! centre! and! serves! as! the!main! centre! for! all! the! genetic! clinics!
(Figure$8).!KMGC!will!be!referred!to!as!the!Genetic!Centre!in!the!rest!of!the!thesis.!
All!genetic! testing! in! the!public! sector! is!now!carried!out! in! the!Genetic!Centre,!with!









The! main! service! offered! at! the! genetic! centre,! often! the! first! point! of! testing! is!




NOR! and! DAPI! but! are! not! routinely! used! and! only! performed! if! necessary.! If! no!
chromosomal! abnormality! is! detected! the! case! is! then! referred! to! analysis! through!




In! the! mainly! Muslim! country! of! Kuwait,! cousin! marriages! are! permitted! and! first!




isolates! in!which!a! founder! recessive!mutation!can! rise! to!a!high! frequency.! In!Saudi!
Arabia!a!first!cousin!marriage!rate!was!reported!at!57.7%!and!reaching!more!than!80%!
in! certain! areas! (Al0Owain,! Al0Zaidan! et! al.! 2012).! Reported! consanguinity! in! Kuwait!
ranged!from!44.8%!to!54.3%!across!three!different!studies!(Al0Kandari!and!Crews!2011)!
Consanguinity! increases! the! coefficient! of! inbreeding,! which! is! defined! as! the!
percentage! of! the! genome! that! is! identical! by! descent! or! homozygous,! this! in! turn!
increases! the! likelihood!of! a!pathogenic!mutation!being! found! in! a!homoallelic! state!
and!a!familial!disorder!is!most!likely!to!be!caused!by!an!autosomal!recessive!mode!of!
inheritance! (Alkuraya! 2010).! This! makes! consanguineous! families! useful! in!




the! offspring! of! first0cousin! marriages! compared! to! non0consanguineous! marriages,!














The! reasons! for! families! to!get! their! children! tested! for!disabilities! include!admission!
into!specialist!schools!and!claiming!disability!benefits.!Genetic!testing!is!requested!for!
elder! children! and! sibs! to! identify! a! genetic! factor! either! to! assist! in! a! planned!
pregnancy!or!for!pre0marital!counselling.!!!!
The! samples! used! in! this! study! can! be! divided! into! two! sets,! one! for! non0specific!
intellectual! disability! (ID),!which!were! selected! based! on! the! criteria! below,! and! the!
other!for!families!with!one!member!with!Rubinstein!Taybi!Syndrome!(RTS),!these!were!
selected! by! the! clinician’s! pre0diagnosis! of! the! disorder! based! on! distinct! clinical!
features! (See!Table$ 2! for! list! of! samples).! ! For!most! ID! and! some!RTS!blood! samples!
collected,!DNA!was!extracted!in!the!laboratory!by!the!author.!For!samples!in!the!DNA!
bank,!consent!was!taken!before!including!them!in!the!study.!The!author!was!involved!
in! the! selection! process! and! even! contacted! some! of! the! selected! families! from! the!
registry! books,! searching! patient! files! and! attended!most! of! the! genetic! counselling!

































pedigree.! ! DNA! samples! were! available! from! individuals! that! are! labeled! in! the!
pedigrees.!Each! individual!was!given!a!unique!number,!which! is!used! in! labelling! the!
pedigree!for!easy!reference.!All!pedigrees!were!created!using!Progeny!7!software.!For!
marital! relationships! a! double! line! is! used! to! refer! to! consanguinity! through! first,! or!
second!cousin!marriage!or!being! related! few!generations!back.! Intelligence! score! for!
individuals!was! determined! from! the!Wechsler! Intelligence! Scale! for! Children! (WISC)!
and!was!performed!by!psychologists!at!the!Genetic!Centre.!!
Pedigrees!show!individuals!affected!with!ID!(MR=Y),!with!the!proband!indicated!by!an!
arrowhead! as! exemplified! in! Figure 9.! below,! females! are!referred! to! with! a! circle! 












































































































15 3 6 Distant+cousins
16 2 6 Distant+cousins
13 2 7 1st+cousin
14 4 9 Distant+cousins
11 3 12 Distant+cousins
12 2 6 2nd+cousins
9 2 7 1st+cousins
10 2 3 1st+cousins
7 3 8 Distant+cousins
8 3 6 Distant+cousins
5 2 7 1st+cousins
6 4 9 1st+cousins
3 2 12 Distant+cousins
4 3 6 1st+cousins
1 4 6 Distant+cousins








































D 1 D.1 Unknown 1 Unknown
















I 1 I.1 Unknown 4 1st+cousins
J.1 Unknown
J.2 Unknown
J 2 8 Distant+cousins
A 2 6 Distant+cousins
B 2 2 1st+cousins
! 58!

















unaffected! sibs! with! parents! who! are! second! cousins.! The! affected! sibs! were!
ascertained!in!the!Genetic!Centre.!The!elder!sister,!individual!2.2,!has!moderate!ID!with!
some!dysmorphic!features!that!include!a!long!face,!microcephaly,!delayed!eruption!of!
teeth,! right! Simian! crease,! bilateral! clinodactyly! of! the! fifth! fingers! and! an! abnormal!
gait.!Her!karyotype!results,!via!G0banding,!were!of!a!normal!female!46,!XX.!Amino!acid!







with!unsteady! small!head,! spasm,!with! limited!abduction!of! the! legs!and!brisk! lower!
limb! reflexes.!He!has!no!dysmorphic! feature! and!has! a!normal! karyotype!and!amino!










Results! for! FRAX0A! and! E! mutation! expansion! for! both! siblings! were! negative.! In!






Family!4! (Figure$ 13)! consists!of! three!affected!male! sibs!and! three!unaffected! female!
sibs!born!to!1st!cousin!parents.!The!first!affected!sib!has!moderate!ID!with!an!overall!IQ!
of!38.!The!second!affected!sib!has!severe! ID!with!an! IQ! less! than!35.!While! the!third!
affected!sib,!individual!4.1!in!pedigree!2.4,!has!borderline!ID.!!
Results!for!FRAX0A!and!E!mutation!expansion!for!all!siblings!were!negative.!In!addition,!







Family! 5! (Figure$ 14)! consists!of! two!affected! sibs!with! ID,! and! five!unaffected! sibs! to!
consanguineous!first!cousin!parents.!The!grandparents!from!the!maternal!side!are!also!
first! cousins.! Other! disorders! in! the! family! include! visual! impairment,! speech! defect!
and!constrictive!paralysis.!!













Family! 6! (Figure$ 15)! consists! of! nine! children! to! first! cousin! parents!with! 4! children!
affected!by!ID.!The!mother!had!six!spontaneous!abortions.!The!mother!and!father!also!
have! consanguineous! parents.! In! addition,! four!males! on! the!maternal! side! have! ID,!
two!of!which!also!have!two!affected!sons!each.!
Individual!6.1!has!mild!ID!with!an!IQ!score!of!61,!while!individual!6.2!has!mild!ID!with!
an! IQ! score!of!56.!Results! for! FRAX0A!and!E!mutation!expansion! for! all! siblings!were!
negative.! In! addition,! FISH! results! and! chromosomal! analysis! using! peripheral! blood!
and!using!standard!G0banding!revealed!normal!karyotype!for!all!sibs!and!the!father.!!!
Parents! were! contacted! for! further! blood! samples! but! failed! to! show! up.! Also,! the!











The! results! for! FRAX0A! and! E! mutation! expansion! for! all! siblings! were! negative.! In!










Results! for! FRAX0A! and! E! mutation! expansion! for! both! siblings! were! negative.! In!







Family! 9! (Figure$ 18)! consists! of! seven! sibs! of! a! consanguineous!marriage,! with! two!
individuals! being! affected!by! ID.! Individual! 9.4!has! severe! ID!with! an! IQ! score!of! 45,!
while!his!brother,! individual!9.2,!has!mild! ID.! In!addition,!a!cousin! from!the!maternal!
side!also!has!ID.!!Individual!9.4,!a!product!of!a!full!term!pregnancy,!was!also!reported!
to!be!hyperactive!with!speech!delay,!has!familial!hirsutism!and!with!the!only!skeletal!
anomaly! being! a! high! arched! foot! (pes! cavus).! An! MRI! scan! revealed! prominent!
Cerebrospinal!fluid!(CSF)!spaces,!dilated!ventricles!and!prominent!sulci.!In!addition,!he!
has!a!mild!hearing!loss!in!one!ear.!









affected!with! ID! as!well! as! their! paternal! grandmother,! six! of! their!maternal! cousins!
and! three! of! their! double! second! cousins.! Individual! 10.1! has! moderate! ID! with! an!
overall!IQ!score!of!40,!while!his!brother!individual!10.2!has!mild!ID!with!an!IQ!score!of!
54.! The! second! brother! was! born! full! term! with! birth! weight! of! 2.7! kg.! He! started!
walking!normally!at!age!1!year!and!a!half!and!had!speech!delay.!!









Family! 11! (Figure$ 20)! consists! of! 12! siblings! from! one!marriage! of! a! consanguineous!















and! one! of! the! siblings! have! sickle! cell! anemia.! No! other! genetic! disorders! were!








Family! 13! (Figure$ 22)! consists! of! seven! children! of! a! first! cousin!marriage! with! two!
affected!female!sibs.!Both!parents!have!consanguineous!parents.!The!cousin!of!the!two!
affected! individuals! is! also! affected! with! ID.! Individual! 13.1! has! severe! ID! with! an!
overall! IQ! of! 31.! Also,! this! individual! has! speech! defect! and! speech! therapy! was!
recommended.!In!addition,!individual!13.2!has!mild!ID!with!an!IQ!of!68.!
Results! for! FRAX0A! and! E! mutation! expansion! for! both! sisters! were! negative.! In!







Family! 14! (Figure$ 23)! consists! of! 9! sibs! to! consanguineous! parents,! including! four!
affected! individuals.!Two!out!of! their! five!double!cousins!are!also!affected!as!well!as!




Results! for! FRAX0A! and! E!mutation! expansion! for! all! affected! sibs! were! negative.! In!







Family! 15! (Figure$ 24)! consists! of! 14! children! to! consanguineous! parents,! with! six!
affected!individuals!with!ID,!two!of!which!also!have!epilepsy.!There!is!also!one!affected!
cousin.! Individual! 15.1! has! severe! ID! with! an! overall! IQ! of! 34,! individual! 15.2! has!
moderate!ID!with!an!overall!IQ!of!45,!and!individual!15.3!has!severe!ID.!!
Results! for! FRAX0A! and! E!mutation! expansion! for! all! affected! sibs! were! negative.! In!







Family! 16! (Figure$ 25)! consists! of! six! siblings,! including! two! affected! with! ID,! to!
consanguineous! parents.! Both! affected! males! individual! 16.1! and! his! brother! have!
moderate!ID!with!an!overall!IQ!of!45.!
Results! for! FRAX0A! and! E! mutation! expansion! for! both! brothers! were! negative.! In!














!Family!A! (Figure$ 26)! consists!of! six! sibs! to! consanguineous!parents!of!Bedouin!origin!
and!Saudi!nationality,! two!of!which,! individual!A.1!and!A.2!have!clinical! features!that!
include!peaked!nose,!short!stature,!prominent!ears,!hyper!mobility!of! joints,! low!hair!
line! and! ID.! Upon! medical! examination! multiple! congenital! anomaly/mental!
retardation! (MCA/MR)! syndrome!was! suggested!with! features! being! consistent!with!
RTS.!Chromosomal!analysis!using!peripheral!blood!and!using!standard!G0banding!and!






Family! B! (Figure$ 27)! is! of! a! consanguineous! marriage.! The! clinicians! at! the! Genetic!
Centre!saw!the!proband,!individual!B.2,!back!in!2001.!!He!was!given!an!overall!IQ!of!63!
that! corresponds! to!mild! ID.!He!was!also!diagnosed!with!hyperactivity,! epilepsy,! and!
hypothyroidism;! he! was! on! growth! hormone! therapy! and! was! diagnosed! with!
Rubinstein!Taybi!syndrome!based!on!the!clinical!features!in!the!summary!Table$4.!He!
was! tested! negative! for! FRAX0A! and! E.! In! addition,! a! CT! brain! scan! showed! normal!
results.!!
His! sister,! individual!B.1,!was!also!diagnosed!with!moderate! ID!based!on!an! IQ!of!48!










Family!C! (Figure$28)! consists!of!a! single!child!of!unrelated!parents.!The!proband!was!
born!of! full0term!normal! vaginal!delivery!at!a!weight!of!3kg.!At!age! two!her!medical!
report!included!global!developmental!delay,!microcephaly,!subnormal!growth,!gastro0
















3.85! kg! to! a! father! at! age! 30! and!mother! 36! years! of! age.! There!were! no! postnatal!
complications.! She! was! referred! to! the! genetic! centre! for! mild! microcephaly! and!
developmental! delays.! Chromosomal! analysis! using! peripheral! blood! and! using!










Family! F! (Figure$ 31)! consists! of! five! sibs! to! unrelated! parents,! the! mother! being!






Family! G! (Figure$ 32)! consists! of! seven! sibs! with! the! youngest,! individual! G.1,! being!
affected!with!RTS,!having!dysmorphic! features,! congenital!heart!problem,!mild! ID,!as!
well! as! severe! visual! impairment.! His! birth! was! normal! after! full! term! at! weight! of!
! 79!
3.45kg! a! 420year0old! father! and! 360year0old! mother.! Chromosomal! analysis! using!
peripheral! blood! and! using! standard!G0banding! revealed! normal! karyotype! of! 46,XY.!
Skeletal!survey!and!audiometry!was!normal.!IQ!was!reported!at!a!score!of!58.!Clinical!










and! dysmorphic! features! including! broad! thumbs! and! toes.! The! individual! was! a!
preterm! at! 32! weeks! with! birth! weight! of! 1.07Kg,! admitted! to! NICU! for! 3! months.!
Sequencing!of!the!CREBBP!gene!for!all!exon!1!to!31!was!carried!out!in!Germany!and!no!
! 80!






Family! I! (Figure$ 34)! consists! of! four! sibs! to! consanguineous! parents! including! one!
affected!child,!individual!I.1,!with!RTS.!The!proband!was!diagnosed!at!age!6!months!to!






Family! J! (Figure$ 35)! consists! of! eight! siblings! to! consanguineous!parents.! Two!of! the!
sibs!have!RTS.!The!FISH!results!and!chromosomal!analysis!using!peripheral!blood!and!








































































unaffected! individuals!when!possible.! It!was!difficult! to!gather!more!DNA!as!patients!
did!not!come!back!even!when!an!appointment!was!booked!for!blood!extraction.!This!
could! be! partly! because! the! study! did! not! have! an! immediate! impact! on! the! family.!
More! families! were! selected! initially! but! some! declined! as! they! felt! that! it! was! not!
worth!going!through!the!hassle!of!blood!extraction!nor!did!they!want!their!children!to!
miss! school.! ID! level! ranged! from! profound! to! severe,!with! variance! found! amongst!
sibs.! Consent! was! given! for! all! the! samples! used! even! if! the! blood! was! not! initially!
extracted!for!the!purpose!of!the!study.!!
For!RTS! cases,!diagnosis!was!based!on! clinical! features!only!and! some! samples!were!
sent!for!CREBBP!sequencing!abroad!with!no!mutations!reported.!Although!RTS!is!often!
considered!as!a!de!novo!dominant!disorder,!three!of!the!ten!families!in!this!study!had!
two! affected! sibs,! suggesting! another! mode! of! inheritance! or! perhaps! a! parental!
mosaicsm,!which!might!not!have!showed!full!penetrance!in!one!of!the!parents.!!
These! samples! were! used! to! evaluate! experimental! design,! laboratory! techniques,!







































































































































































































































































































































































Description version 28; 02-11-2011
SALSA® MLPA® probemix P245 Microdeletion syndromes-1
 Page 3 of 13
Table 1. SALSA MLPA P245-A2 Microdeletion-1 probemix 
Length (nt) SALSA MLPA probe Chromosomal  position Syndrome 
64-70-76-82 Q-fragments: DNA quantity; only visible with less than 100 ng sample DNA 
88-92-96 D-fragments: Low signal of 88 or 96 nt fragment indicates incomplete denaturation 
100 X-fragment: Specific for the X chromosome (new from lot 1008 onwards) 
105 Y-fragment: Specific for the Y chromosome (new from lot 1008 onwards) 
118 Y-fragment: Specific for the Y chromosome 
130 TNFRSF4 Probe 02269–L01761 1p36.33 1p36 deletion syndrome 
136 GATA3 Probe 07632–L07317 10p15.1 DiGeorge region 2 (10p) 
142 PAFAH1B1 Probe 04120–L03532 17p13.3 Miller-Dieker region 
148 MECP2 Probe 09310–L09999 Xq28 MECP2 / Xq28 duplication 
153 NSD1 Probe 02595–L08077 5q35.3 Sotos syndrome 
160 UBE3A Probe 04620–L00863 15q11.2 Prader-Willi / Angelman 
166 GABRD Probe 04690–L07966 1p36.33 1p36 deletion syndrome 
172 CREBBP Probe 03087–L02487 16p13.3 Rubinstein-Taybi syndrome 
178 GNB1 Probe 02890–L07968 1p36.33 1p36 deletion syndrome 
184 MECP2 Probe 09311–L10002 Xq28 MECP2 / Xq28 duplication 
190 * SEMA7A Probe 08380–L10003 15q24.1 “15q24 deletion syndrome” 
196 CLDN5 Probe 01218–L06270 22q11.21 DiGeorge syndrome 
202 MECP2 Probe 03409–L02797 Xq28 MECP2 / Xq28 duplication 
208 GP1BB Probe 05464–L10114 22q11.21 DiGeorge syndrome 
214 NDN Probe 06282–L01542 15q11.2 Prader-Willi / Angelman 
220 PAX6 Probe 03253–L02690 11p13 WAGR syndrome 
226 MAPT Probe 07856–L08385 17q21.31 “17q21 microdeletion” 
232 LETM1 Probe 04190–L05920 4p16.3 Wolf-Hirschhorn region 
238 PAFAH1B1 Probe 01443–L08394 17p13.3 Miller-Dieker region 
246 SNRPN Probe 02026–L10004 15q11.2 Prader-Willi / Angelman 
254 † SHANK3 Probe 10181-L11409 22q13.33 22q13 / Phelan-McDermid 
260 NF1 Probe 03778–L11180 17q11.2 NF1 microdeletion syndrome 
267 FANCL Probe 08386–L11411 2p16.1 “2p16.1 deletion syndrome” 
274 LRRC48 Probe 01452–L00936 17p11.2 Smith-Magenis syndrome 
283 ± CRR9 Probe 01126–L00684 5p15.3 Cri du Chat syndrome 
292 SNRPN Probe 01318–L07970 15q11.2 Prader-Willi / Angelman 
297 † DMD Probe 01412–L01059 Xp21.2 Chromosome X control probe 
304 LLGL1 Probe 01453–L08499 17p11.2 Smith-Magenis syndrome 
310 ELN Probe 01333–L00876 7q11.23 Williams syndrome 
319 TGFBR1 Probe 04652–L04036 9q22.33 “9q22.3 deletion syndrome” 
326 CYP1A1 Probe 06811–L06406 15q24.1 “15q24 deletion syndrome” 
335 NF1 Probe 02508–L02620 17q11.2 NF1 microdeletion syndrome 
341 MAPT Probe 07857–L08501 17q21.31 “17q21 microdeletion” 
349 Hs.538604 Probe 01232–L07388 10p15.1 DiGeorge region 2 (10p) 
355 DLG1 Probe 08395–L08249 3q29 “3q29 deletion syndrome” 
364 ELN Probe 01336-L00878 7q11.23 Williams syndrome 
373 SNAP29 Probe 01235–L00773 22q11.21 DiGeorge syndrome 
382 † SHANK3 Probe 10182–L11174 22q13.33 22q13 / Phelan-McDermid 
391 LIMK1 Probe 01337–L02333 7q11.23 Williams syndrome 
401 TRPS1 Probe 03081–L07411 8q24.12 Langer-Giedion syndrome 
409 TGFBR1 Probe 04653–L10006 9q22.33 “9q22.3 deletion syndrome” 
418 DLG1 Probe 08401–L08255 3q29 “3q29 deletion syndrome” 
427 † EIF3S3 Probe 01108–L00679 8q24.11 Langer-Giedion syndrome 
437 TERT Probe 03761–L02477 5p15.33 Cri du Chat syndrome 
445 WHSC1 Probe 06058–L05513 4p16.3 Wolf-Hirschhorn region 
454 NSD1 Probe 02600–L02071 5q35.3 Sotos syndrome 
466 † RAI1 Probe 09440-L11412 17p11.2 Smith-Magenis syndrome 
474 CRHR1 Probe 07859-L07620 17q21.31 “17q21 microdeletion” 
484 † REL Probe 09860-L10628 2p16.1 “2p16.1 deletion syndrome” 
* A Spanish lab has reported a deletion of the target sequence of this probe in a healthy individual. 










Description version 12; 27-06-2011
SALSA MLPA P036 Human telomere-3 Page 3 of 8
Table 1. SALSA MLPA P036-E1 Human Telomere-3 probemix
Length (nt) Chromosomal position Gene detected 
SALSA MLPA 
probe MapView build 36 position 
64-70-76-82 Q-fragments: DNA quantity; only visible with less than 100 ng sample DNA 
88-92-96 D-fragments: Low signal of 88 or 96 nt fragment indicates incomplete denaturation 
100 X-fragment: Specific for the X chromosome 
105 Y-fragment: Specific for the Y chromosome 
118 Y-fragment: Specific for the Y chromosome 
130 § 1p TNFRSF4 02269-L01761 01-001.14 
136 2p ACP1 02274-L08758 02-000.25 
142 3p CHL1 01721-L01329 03-000.34 
151 4p PIGG (FLJ20265) 02005-L02047 04-000.50 
158 5p PDCD6 01723-L01327 05-000.37 
166 6p IRF4 01724-L02048 06-000.34 
172 7p ADAP1 (CENTA1) 02275-L02049 07-000.93 
179 8p FBXO25 02397-L01845 08-000.40 
186 9p DMRT1 01727-L02050 09-000.84 
193 10p DIP2C (KIAA0934) 02277-L01768 10-000.48 
202 11p RIC8A (RIC-8) 03315-L02733 11-000.20 
208 12p SLC6A12 02276-L01767 12-000.17 
219 + 13q-cen PSPC1 02399-L01847 13-019.24 (Acrocentric chromosome) 
227 + 14q-cen CCNB1IP1 (HEI10) 01732-L01318 14-019.86 (Acrocentric chromosome) 
235 + 15q-cen MKRN3 07291-L08858 15-021.36 (Acrocentric chromosome) 
242 16p POLR3K 01734-L01316 16-000.04 
250 17p RPH3AL 01735-L01315 17-000.17 
258 18p USP14 01736-L02051 18-000.19 
265 19p CDC34 01737-L01313 19-000.49 
274 20p SOX12 02396-L01844 20-000.26 
283  + 21q-cen RBM11 01739-L01311 21-014.51 (Acrocentric chromosome) 
289  + 22q-cen BID 01740-L01310 22-016.61 (Acrocentric chromosome) 
298 Xp/Yp (PAR1) SHOX 01148-L01331 X/Y-000.52 (PAR1 region) 
307 1q SH3BP5L (KIAA1720) 02392-L02149 01-247.08 (0.2 Mb from telomere) 
313 2q CAPN10 01742-L01308 02-241.18 (1.6 Mb from telomere) 
322 3q BDH1 02013-L02052 03-198.76 (0.7 Mb from telomere) 
330 § 4q TRIML2 12050-L11446 04-189.26 (2.0 Mb from telomere) 
337 5q GNB2L1 03319-L02737 05-180.60 (0.2 Mb from telomere) 
346 6q PSMB1 01746-L01304 06-170.69 (0.5 Mb from telomere) 
355 7q VIPR2 01747-L01303 07-158.60 (0.3 Mb from telomere) 
361 8q ZC3H3 (KIAA0150) 01748-L01302 08-144.69 (1.6 Mb from telomere) 
372 9q EHMT1 08205-L08170 09-139.83 (0.2 Mb from telomere) 
379 10q PAOX (PAO) 09142-L09953 10-135.05 (0.2 Mb from telomere) 
386 11q NCAPD3 (KIAA0056) 01751-L01299 11-133.60 (1.2 Mb from telomere) 
395 12q ZNF10 02687-L02154 12-132.24 (0.2 Mb from telomere) 
402 13q F7 01753-L01297 13-112.82 (1.3 Mb from telomere) 
411 14q MTA1 02778-L02201 14-105.00 (1.3 Mb from telomere) 
418 15q ALDH1A3 01755-L01295 15-099.26 (1.0 Mb from telomere) 
426 16q GAS8 (GAS11) 03201-L02669 16-088.63 (0.2 Mb from telomere) 
434 17q TBCD 01757-L01293 17-078.45 (0.5 Mb from telomere) 
441 18q C18orf22 (FLJ21172) 01758-L01292 18-075.90 (0.2 Mb from telomere) 
450 19q CHMP2A (BC-2) 09143-L10626 19-063.75 (0.9 Mb from telomere) 
458 20q OPRL1 02688-L02884 20-062.19 (0.2 Mb from telomere) 
466 21q PRMT2 (HMT1) 02586-L02059 21-046.89 (0.1 Mb from telomere) 
475 22q RABL2B 01762-L08761 22-049.55 (0.1 Mb from telomere) 
483 Xq/Yq (PAR2) VAMP7 (SYBL1) 01763-L02150 X/Y-154.78 (PAR2; 0.1 Mb from telom.) 
 
Many notes on individual probes are present on page 7 and 8.
§ New in version E1 (from lot 0808 onwards)
+ The 13, 14, 15, 21 & 22 q-cen probes target the q arm close to the centromer (acrocentric chromosomes).
Complete probe sequences are available on request: info@mlpa.com. Please notify us of any mistakes and 












Description version 34; 27-06-2011
SALSA MLPA kit P070 Human Telomere-5 Page 4 of 9
Table 1. SALSA MLPA P070-B2 Human Telomere-5 probemix




 probe MapView build 36 position 
64-70-76-82 Q-fragments: DNA quantity; only visible with less than 100 ng sample DNA 
88-92-96 D-fragments: Low signal of 88 or 96 nt fragment indicates incomplete denaturation (autosomal) 
100 X-fragment: Specific for the X chromosome (AMOT gene ; X-111.95) 
105 Y-fragment: Specific for the Y chromosome (UTY gene ; Y-013.98) 
118 Y-fragment: Specific for the Y chromosome (DDX3Y gene ; Y-013.54) 
132 1q SH3BP5L (KIAA1720) 04084-L03605 01-247.08 
139 2q ATG4B (=APG4B) 02781-L03168 02-242.25 
145 3q KIAA0226 02690-L02842 03-198.88 
152 4q FRG1 02691-L02843 04-191.10 
160 5q GNB2L1 02790-L02232 05-180.60 
166 6q TBP 02694-L02844 06-170.71 
172 7q VIPR2 02793-L03167 07-158.63 
179 8q RECQL4 02695-L00610 08-145.71 
186 9q EHMT1 02792-L02846 09-139.78 
193 10q ECHS1 02696-L02847 10-135.03 
202 11q IGSF9B (=KIAA1030) 02697-L02848 11-133.29 
211 12q ZNF10 02686-L02849 12-132.24 
218 13q CDC16 02698-L00753 13-114.03 
226 14q MTA1 02699-L02850 14-104.99 
233 15q TM2D3 (=FLJ22604) 02701-L02851 15-100.01 
241 16q GAS8 (=GAS11) 02702-L00734 16-088.64 
250 17q SECTM1 02703-L03169 17-077.87 
258 18q CTDP1 02704-L03607 18-075.58 
265 19q CHMP2A (=BC-2) 02705-L02853 19-063.76 
274 20q UCKL1 (=FLJ20517) 02706-L00642 20-062.05 
281 21q S100B 02587-L02854 21-046.85 
290 22q ARSA 02707-L00661 22-049.41 
298 X/Yq (PAR2) VAMP7 (=SYBL1) 02708-L02855   X-154.82 + Y-057.68 (PAR region) 
306 1p TNFRSF18 02270-L01762 01-001.13 
315 2p ACP1 02709-L02856 02-000.27 
323 3p CHL1 02896-L02363 03-000.34 
329 4p PIGG 14440-L16146 04-000.51 
337 5p CCDC127 (=LOC133957) 02791-L02233 05-000.26 
346 6p IRF4 04077-L03462 06-000.34 
355 7p UNC84A 02780-L02857 07-000.84 
362 8p FBXO25 02715-L00973 08-000.40 
370 9p DOCK8 (=FLJ00026) 02716-L00688 09-000.38 
379 10p ZMYND11 (=BS69) 05180-L16343 10-000.22 
387 11p BET1L 02784-L02226 11-000.20 
393 12p JARID1A (=RBBP2) 02787-L02229 12-000.29 
402 + “13p” PSPC1 02717-L03608 13-019.25 (Acrocentric) 
409 + “14p” PARP2 (=ADPRTL2) 02718-L00732 14-019.90 (Acrocentric) 
418 + “15p” NDN 04026-L01542 15-021.48 (Acrocentric) 
427 16p DECR2 02720-L00648 16-000.40 
436 17p RPH3AL 04081-L03465 17-000.18 
444 18p THOC1 02789-L02231 18-000.20 
450 19p PPAP2C 03501-L02880 19-000.23 
459 20p ZCCHC3 (=FLJ22115) 02723-L00641 20-000.23 
466 + “21p” HSPA13 (=STCH) 02724-L00334 21-014.68 (Acrocentric) 
478 + “22p” IL17RA 02725-L16344 22-015.96 (Acrocentric) 
484 X/Yp (PAR1) SHOX 03714-L16345 X/Y-000.52 (PAR region) 
+ The 13,  14,  15,  21  &  22  “p”  probes  in  fact  target the q arm, as these chromosomes are acrocentric.
The lengths of some probes in this description have been adjusted as compared to previous versions.









































































































































































































































































































































































































1.1 y m 1.1 1.1
1.2 y m 1.2
2.1 y m 2.1 2.1
2.2 y f 2.2
3.1 y m 3.1 3.1
3.2 y m 3.2 '
4.1 y m 4.1 4.1
5.1 y f 5.1 5.1
6.1 y f 6.1 6.1
7.1 y f 7.1 7.1 S0260
7.2 n f 7.2
7.3 y f 7.3 S0261
8.1 y f 8.1 8.1
9.1 n m 9.1 9.1
9.2 y m 9.2
9.3 n m failed
9.3 n m failed
10.1 y m 10.1
11.1 y f 11.1 failed
12.1 y m failed
13.1 y f 13.1
15.1 y f 15.1
16.1 y m 16.1
A.1 y f 7 ' A.1
A.2 y m 8 A.2
B.1 y f 6 B.1 failed
B.2 y m failed
B.3 n f 1
C.1 y f 2 C.1
D.1 y m 3 D.1
E.1 y f 4 E.1
F.1 y m 5
G.1 y m 9 G.1
H.1 y m 10
I.1 y f 11 I.1
J.1 y f 13 J.1
J.2 y f 12
cc1 n M cc1
cc3 n M cc3



































































CREBBP nonsense mutations CREBBP deletions and insertions 
Exon Mutation Protein Exon Mutation Protein 
Exon 1 c.68C>A p.S23X Exon 2 c.86_233 del 148 p.D29fsX37
Exon 2 c.304C>T p.Q102X Exon 2 c.139del A ins 13 p.N47delinsIHHEL
Exon 2 c.406C>T p.Q136X Exon 2 c.235 del G p.G79fsX86
Exon 4 c.1066C>T p.Q356X Exon 2 c.474_493 del 20 p.Q158fsX173
Exon 4 c.1108C>T p.R370X Exon 3 c.840 dup T p.S81fsX281
Exon 4 c.1108C>T p.R370X Exon 3 c.904_905 del AG p.S302fsX348
Exon 4 c.1108C>T p.R370X Exon 6 c.1381_1388 del 8 p.G461fsX469
Exon 4 c.1108C>T p.R370X Exon 6 c.1481 dup A! p.N494fsX527
Exon 4 c.1108C>T p.R370X Exon 8 c.1733 del C! p.P578fsX588
Exon 5 c.1237C>T p.R413X Exon 8 c.1738 dup A p.A581fsX586
Exon 5 c.1237C>T p.R413X Exon 9 c.1891_1895 del 4 p.A631fsX632
Exon 5 c.1270C>T p.R424X Exon 10 c.2045 dup A! p.P683fsX725
Exon 5 c.1270C>T p.R424X Exon 14 c.2749 dup A! p.T917fsX969
Exon 5 c.1270C>T p.R424X Exon 14 c.2827 del C! p.Q943fsX997
Exon 10 c.1984C>T p.Q662X Exon 16 c.3096 dup T! p.K1033fsX1033
Exon 15 c.2986G>T p.E996X Exon 17 c.3352 dup CC p.Q1118fsX1130
Exon 18 c.3517C>T p.R1173X Exon 18 c.3396_3400 del 5 p.P1132fsX1166
Exon 19 c.3639C>A p.C1213X Exon 18 c.3432_3433 del AG p.T1144fsX1168
Exon 21 c.3805A>T p.K1269X Exon 18 c.3545 dup C p.A1182fsX1186
Exon 27 c.4398T>A p.Y1466X Exon 20 c.3715_3716 del AA p.K1239fsX1252
Exon 27 c.4435G>T p.G1479X Exon 20 c.3767_3769 del CAC p.S1256X
Exon 27 c.4492C>T p.R1498X Exon 21 c.3824 dup T p.F1275fsX1282
Exon 27 c.4492C>T p.R1498X Exon 25 c.4256_4258 del CT p.S1419fsX1419
Exon 28 c.4669C>T p.Q1558X Exon 26 c.4319_4320 del TC p.F1440fsX1451
Exon 29 c.4879A>T p.K1627X Exon 26 c.4322 dup C p.R1441fsX1452
Exon 31 c.5635C>T p.Q1879X Exon 27 c.4398_4399insT p.V1467fsX1467
Exon 31 c.6010C>T p.R2004X Exon 28 c.4611 del G p.L1537fsX1549
Exon 31 c.6019C>T p.Q2007X Exon 29 c.4837 del G p.V1613fsX1634
Exon 31 c.6127C>T p.Q2043X Exon 29 c.4898_4908 del 11 p.F1633fsX1655
Exon 31 c.6133C>T p.Q2045X Exon 30 c.4945 del A p.I1649fsX1743
Exon 31 c.6283C>T p.Q2095X Exon 30 c.4963 del C p.L1655fsX1743
CREBBP Missense mutations Exon 31 c.5212 ins 14 p.H1738fsX1748
Exon Mutation Protein Exon 31 c.5222 del AG p.K1741fsX1749
Exon 1 c.40A>G p.R14G Exon 31 c.5793 dup C p.1932TfsX1965
Exon 15 c.2941G>A p.A981T Exon 31 c.6043 del A p.S2015fsX2039
Exon 18 c.3524A>G p.Y1175C Exon 31 c.6050_6051ins 8 p.P2017fsX2342
Exon 21 c.3832G>A p.E1278K Exon 31 c.6065_6071 del 7 p.Q2022fsX2037
Exon 21 c.3833A>G p.E1278G CREBBP Splice site mutations
Exon 25 c.4238A>C p.H1413P Exon Mutation Protein 
Exon 26 c.4304A>T p.D1435V Exon 4 c.1216 + 1G>A 
Exon 26 c.4340C>T p.T1447I Exon 7 c.1676 + 1G>A 
Exon 26 c.4348T>C p.Y1450H Exon 17 c.3368_3369 + 6 del 7 ins CA 
Exon 27 c.4409A>G p.H1470R Exon 19 c.3698 + 1G>A 
Exon 27 c.4445A>G p.Y1482C Exon 19 c.3698 + 5A>T
Exon 28 c.4627G>T p.D1543Y Exon 20 c.3779 + 5G>C
Exon 30 c.4951G>C p.D1651H Exon 21 c.3836 + 1G>A
Exon 30 c.4991G>A p.R1664H Exon 22 c.3837-2 A>T
Exon 30 c.4991G>A p.R1664H Exon 23 c.3915-1 G>A
Exon 31 c.6661A>C p.M2221L Exon 24 c.4133 + 1G>A 
Exon 31 c.6728C>T p.A2243V Exon 25 c.4280 + 2T>C
Exon 27 c.4559A>G p.1520R/splice site
Adapted from Roelfsema and Peters 2007 Exon 28 c.4561-5 C>G























A"(RTS"1) A.1 Y 7
A"(RTS"1) A.2 Y 8
B"RTS"2 B.1 Y 6
B"RTS"2 B.3 N 1
C C.1 Y 2
D D.1 Y 3
E E.1 Y 4
F F.1 Y 5
G G.1 Y 9
H H.1 Y 10
I I.1 Y 11
J J.1 Y 13
































































































!SCORE START! END QSIZE IDENTITY CHRO STRAND START!! END! !SPAN
exon!18! 365 1 365 365 100.00% 16 = 3807752 3808116 365
18_1 196 11 274 369 87.50% 16 = 3807827 3808092 266
18_2 38 10 48 370 100.00% 16 = 3808052 3808091 40
18_3!! 329 1 336 360 99.20% 16 = 3807774 3808111 338
18_4 311 6 325 425 99.10% 16 = 3807780 3808103 324
18_5
18_6 325 6 341 359 98.60% 16 = 3807780 3808117 338
18_7
18_8
18_9 322 6 337 497 98.80% 16 = 3807780 3808115 336
18_10 318 3 330 358 98.80% 16 = 3807778 3808109 332
18_11 329 2 380 416 98.60% 16 = 3807778 3808331 554
18_12 313 6 333 360 97.90% 16 = 3807780 3808109 330

























































































































































































































































































































































































































































































































detected$ DNA$ DD$ XFFrag$ YFFrag$
0Ve! NA!! 0!/!50! Too!low! Not!OK?! Not!detected! Not!detected!
1.1! M! 15!/!50! Too!low! Not!OK?! Detected! High!
2.1! M! 4!/!50! Too!low! Not!OK?! Detected! Not!detected!
4.1! M! 44!/!50! OK! Not!OK?! Detected! Not!detected!
5.1! F! 35!/!50! OK! Not!OK?! Detected! Not!detected!
6.1! F! 44!/!50! OK! Not!OK?! Detected! Not!detected!
7.1! F! 20!/!50! OK! Not!OK?! Detected! Not!detected!
9.1! M! 19!/!50! OK! Not!OK?! Detected! Detected!
11.1! F! 44!/!50! OK! Not!OK?! Detected! Not!detected!
15.1! F! 36!/!50! OK! Not!OK?! Detected! Not!detected!
16.1! M! 36!/!50! OK! Not!OK?! Detected! Detected!
B.1! F! 36!/!50! OK! Not!OK?! Detected! Not!detected!
C.1! F! 42!/!50! OK! Not!OK?! Detected! Not!detected!
D.1! M! 17!/!50! OK! Not!OK?! Detected! Detected!
G.1! M! 39!/!50! OK! Not!OK?! High! High!
I.1! M! 44!/!50! OK! Not!OK?! Detected! Not!detected!
CC1! M! 42!/!50! OK! Not!OK?! Detected! Detected!
CC3! M! 40!/!50! OK! Not!OK?! Detected! Detected!







detected$ DNA$ DD$ XFFrag$ YFFrag$
0Ve! NA! 0!/!47! Too!low! Not!OK?! Not!detected! Not!detected!
1.1! M! 26!/!47! OK! OK! Detected! Detected!
2.1! M! 47!/!47! OK! OK! Detected! Detected!
3.1! M! 47!/!47! OK! OK! Detected! Detected!
4.1! M! 46!/!47! OK! OK! Detected! Not!detected!
5.1! F! 46!/!47! OK! OK! Detected! Not!detected!
6.1! F! 46!/!47! OK! OK! Detected! Not!detected!
7.1! F! 46!/!47! OK! OK! Detected! Not!detected!
9.1! M! 29!/!47! OK! OK! Detected! Detected!
11.1! F! 46!/!47! OK! OK! Detected! Not!detected!
13.1! F! 46!/!47! OK! OK! Detected! Not!detected!
15.1! F! 46!/!47! OK! OK! Detected! Not!detected!
B.1! F! 46!/!47! OK! OK! Detected! Not!detected!
C.1! F! 46!/!47! OK! OK! Detected! Not!detected!
D.1! M! 45!/!47! OK! OK! Detected! Detected!
G.1! M! 47!/!47! OK! OK! Detected! Detected!
I.1! F! 46!/!47! OK! OK! Detected! Not!detected!
J.1! F! 44!/!47! OK! OK! Detected! Not!detected!
CC1! M! 47!/!47! OK! OK! Detected! Detected!
CC3! M! 46!/!47! OK! OK! Detected! Detected!











detected$ DNA$ DD$ XFFrag$ YFFrag$
0Ve! NA! 0!/!47! OK! Not!OK?! Not!detected! Not!detected!
1.1! M! 14!/!47! OK! OK! Low! Detected!
2.1! M! 46!/!47! OK! OK! Detected! Detected!
3.1! M! 46!/!47! OK! OK! Detected! Detected!
4.1! M! 45!/!47! OK! OK! Detected! Not!detected!
5.1! F! 36!/!47! OK! OK! Detected! Not!detected!
7.1! F! 45!/!47! OK! OK! Detected! Not!detected!
9.1! M! 46!/!47! OK! OK! Detected! Detected!
11.1! F! 45!/!47! OK! OK! Detected! Not!detected!
13.1! F! 45!/!47! OK! OK! Detected! Not!detected!
15.1! F! 45!/!47! OK! OK! Detected! Not!detected!
16.1! M! 41!/!47! Too!low! Not!OK?! Detected! Detected!
B.1! F! 45!/!47! OK! Not!OK?! Detected! Not!detected!
C.1! F! 45!/!47! OK! OK! Detected! Not!detected!
D.1! M! 46!/!47! OK! OK! Detected! Detected!
G.1! M! 24!/!47! OK! OK! Detected! Detected!
J.1! F! 38!/!47! OK! OK! Detected! Not!detected!
CC1! M! 44!/!47! OK! OK! Detected! Detected!






































































































chr. pos. gene exon gene exon
01p36.33 TNFRSF4 5 TNFRSF18 4b
01q44 SH3BP5L 5 SH3BP5L 3
02p25.3 ACP1 1 ACP1 5
02q37.3 CAPN10 3 ATG4B 7
03p26.3 CHL1 5 CHL1 3
03q29 BDH1 4 KIAA0226 22
04p16.3 PIGG 7b PIGG 8
04q35.2 TRIML2 2 FRG1 1
05p15.33 PDCD6 6 CCDC127 3
05q35.3 GNB2L1 6 GNB2L1 2
06p25.3 IRF4 2 IRF4 3
06q27 PSMB1 5 TBP 2
07p22.3 ADAP1 4 UNC84A 5
07q36.3 VIPR2 3 VIPR2 2
08p23.3 FBXO25 9 FBXO25 8
08q24.3 ZC3H3 2 RECQL4 17
09p24.3 DMRT1 2 DOCK8 23
09q34.3 EHMT1 23 EHMT1 10
10p15.3 DIP2C 4 ZMYND11 2a
10q26.3 PAOX 3 ECHS1 8
11p15.5 RIC8B 3 BET1L 3b
11q25 NCAPD3 2 IGSF9B 20
12p13.33 SLC6A12 19 JARID1A 23
12q24.33 ZNF10 5 ZNF10 5
13q11 PSPC1 2 PSPC1 1
13q34 F7 6 CDC16 8
14q11.2 CCNB1IP1 4 PARP2 16
14q32.33 MTA1 8 MTA1 7
15q11.2 MKRN3 1 NDN 1
15q26.3 ALDH1A3 11 TM2D3 3
16p13.3 POLR3K DECR2 9
16q24.3 GAS8 6 GAS8 11
17p13.3 RPH3AL 5 RPH3AL 2
17q25.3 TBCD 18 SECTM1 4
18p11.32 USP14 7 THOC1 21
18q23 C18orf22 4 CTDP1 9
19p13.3 CDC34 5 PPAP2C 7
19q13.43 CHMP2A 6 CHMP2A 3
20p13 SOX12 1 ZCCHC3 1
20q13.33 OPRL1 3 UCKL1 6
21q11.2 RBM11 1 HSPA13 2
21q22.3 PRMT2 4 S100B 2
22q11.21 BID 4 IL17RA 4
22q13.33 RABL2B 9 ARSA 1
Xp22.33PAR SHOX 4 SHOX 5

























Sample$$ Gender$ MLPA$P036FE1$ MLPA$P070FB2$




11.1! F! normal$ !! CHMP2AF3$:$19q13.43$ 0.66!
!! !! !$ !! ZNF141F1$:$4p16.3$ 0.67$
!! !! !$ !! S100B$F02$:$21q22.3$$ 0.66!
!! !! !$ !! SHOXF5$:$Xp22.33" 0.57!
!! !! !$ !! VAMP7F8$:$Xq28" 0.57!
! 159!
D.1! M! RABL2BF9$:$22q13.33! 0! normal$ !$
!! !! VAMP7F4$:$Xq28! 0! !$ !$
J.1! F! RABL2BF9$:$22q13.33! 0! dismissed$ !$
!! !! VAMP7F4$:$Xq28$ 0$ !$ !!
CC1! M! normal$ !$ ZCCHC3F1$:$20p13$ 0!
!! !! !" !! IL17RAF4$:$22q11.1" 0!
CC3! M! RABL2BF9$:$22q13.33$ 0! failed" !!
CC8! F! normal$ !$ ZCCHC3F1$:$20p13$ 0!
!! !! !$ !$ S100B$F02$:$21q22.3$$ 0!



















































































































































































































































































































































































Intellectual! disability! (ID),! historically! known! as! mental! retardation! (MR),! is! a! highly!
heterogeneous! group! of! disorders,! with! many! known! environmental! and! genetic!
causes.! In! addition! to! ID,! affected! subjects! can! also! have! syndromal! symptoms,!
including! behavioural! problems,! dysmorphism,! growth! abnormalities,! heart! defects,!
epilepsy,!and!other!medical!problem!such!as!deafness.!Microscopy!detects!large0scale!
(>3Mb)! chromosomal! abnormalities,! affecting! many! genes,! in! up! to! 10%! of! cases.!
Although!many!X0linked,!chromosomal!and!genomic!forms!are!now!well!characterised!
(e.g.!Fragile!X,!Down!syndrome!and!Williams!syndrome),!most!cases!display!no!visible!
cytogenetic! abnormality! and! remain! idiopathic.!Heterogeneity!has!hampered!genetic!
analysis,! especially! for! the! autosomal! chromosomes,! where! most! genetic! changes!
associated!with!ID!are!expected!to!lie!(Ropers!2008).!!
However!recent!developments! in! technology,!particularly!DNA!genotyping!arrays!and!
array! comparative! genomic! hybridisation! (aCGH)! have! allowed! the! identification! of!
many! previously! undetectable! microdeletions! and! microduplications,! collectively!




2009),! and! these!are!mainly!dominantly! acting.!However,! there! are! also!CNVs!which!
give! rise! to! ID! through!recessive!mechanisms,! i.e.! through! loss!of! function.!Recessive!



































In! this! study,! DNA! samples! of! affected! individuals! have! been! used! for! cytogenetic!
analysis! to! detect! candidate! genes! associated!with! ID.! As! part! of! the! initial! plan! the!
selection!criteria! for!samples! to!be!used!on!the!arrays!was!supposed!to!be!based!on!
the!result!screening!using!MLPA!in!chapter!5.!!However,!due!to!long!delivery!delays!in!
receiving! the! reagents! and! limited! funding,! samples! for! analysis!were! chosen!on! the!
basis!of!phenotype!and!family!structure.!!One!individual!from!each!family!was!selected!
























potentially! pathogenic! CNVs! based! on! a! study! of! 15,767! children! with! various!
















































































































































estimated!as!3,156,105 kbp in size. In addition, the number of LOH regions 
covering genes, OMIM entries, and the key words mental retardation were 
reported in the results for each individual. Furthermore, the LOH regions 
covering disorders listed on OMIM with the key words “mental retardation” 

















































family Array%# ng/ul% A260 A280 260/280 260/230 ng/ul A260 A280 260/280 260/230 Gender
1 100824601 287.91 5.758 3.176 1.81 1.97 1491.35 29.827 15.812 1.89 2.35 m
1 10120101 292.43 5.849 3.236 1.81 1.94 1398.65 27.973 14.827 1.89 2.32 m
2 100824602 52.23 1.045 0.535 1.95 1.22 1176.53 23.531 12.439 1.89 2.35 m
2 10120602 77.29 1.546 0.784 1.97 1.44 1208.58 24.172 13.214 1.83 2.26 m
3 B0921 51.48 1.03 0.529 1.95 2.03 1102.94 22.06 12.26 1.8 2.23 m
3 10120102 37.32 0.746 0.383 1.95 1.22 1349.72 26.994 14.318 1.89 2.33 m
4 C0921 641.92 12.838 6.849 1.87 2.16 1184.24 23.69 12.67 1.87 2.32 m
5 D0921 91.84 1.837 0.955 1.92 1.5 1165.46 23.31 12.95 1.8 2.25 f
6 10092802 285.52 5.71 3.033 1.88 2.06 1121.82 22.436 12.168 1.84 2.35 f
7 10100601 368.46 7.369 4.01 1.84 2.09 1406.25 28.125 15.006 1.87 2.32 f
7 10100602 115.77 2.315 1.261 1.84 1.75 1414.16 28.283 15.006 1.88 2.35 f
7 10101102 283.84 7.677 4.19 1.83 2.1 1277.01 25.54 13.804 1.85 2.32 f
8 10101101 381.16 7.623 3.951 1.93 1.08 1252.65 25.053 13.469 1.86 2.33 m
9 10121501 115.82 2.316 1.471 1.58 1.2 1249.23 24.985 13.395 1.87 2.35 m
9 10121502 30.83 0.617 0.353 1.75 1.4 1385.18 27.704 14.844 1.87 2.31 m
10 10120801 125.32 2.506 1.382 1.382 1.81 1297 25.94 14.638 1.77 2.24 m
rsts41 10191003 1322.2 26.44 14.2 1.86 1.96 1211.58 24.232 12.837 1.89 2.35 f




























Sample'number' 1.1 1.2 2.1 2.2 3.1 3.2 4.1 5.1 6.1 7.1 7.2 7.3 8.1 9.1 9.2 10.1 A.1 A.2 Total' Average
gender M M M F M M M F F F F F F M M M F M / /
affected'status'(y/n) y y y y y y y y y y n y y n y y y y / /
Total'variations' 111 243 303 365 368 220 219 139 487 150 347 123 264 4910 1634 737 174 728 11522 195.2
'Total'variations'at'85%'confidence 95 154 216 351 298 153 176 103 419 98 265 100 174 4552 1492 621 166 655 10088 153.8
Gains 30 20 16 281 96 5 34 20 280 41 106 33 27 1058 190 491 74 404 3206 59.1
LCSH'regions 28 62 95 38 97 70 70 40 70 28 76 30 71 166 187 59 43 148 1378 45.4
LOH'regions 28 62 98 27 91 70 65 39 55 28 73 30 71 104 99 55 40 93 1128 43.2
Losses 9 10 7 4 11 8 7 4 11 0 8 6 5 3211 1016 11 9 10 4347 5.5

















Sample'number' 1.1 1.2 2.1 2.2 3.1 3.2 4.1 5.1 6.1 7.1 7.2 7.3 8.1 9.1 9.2 10.1 A.1 A.2 Total' Average
gender M M M F M M M F F F F F F M M M F M / /
affected'status'(y/n) y y y y y y y y y y n y y n y y y y / /
Losses 9 10 7 4 11 8 7 4 11 0 8 6 5 3211 1015 11 9 10 4346 7.3
losses'>'200kbp 0 0 0 1 1 0 2 1 0 0 1 0 0 29 11 1 0 0 47 0.4
losses'>'200kbp'covering'gene'and'50'
or'more'markers' 0 0 0 1 0 0 2 0 0 0 0 0 0 23 6 0 0 0 32 0.2
losses'>'200kbp'covering'gene,'
covering'50'or'more'markers,'and'not'
>2'reported'studies'in'DGV 0 0 0 1 0 0 0 0 0 0 0 0 0 8 2 0 0 0 11 0.1
losses'<'200kbp 9 10 7 3 10 8 5 3 11 0 7 6 5 3182 1005 10 9 10 4300 6.9
losses'<'200kbp,'covering'50'or'more'
markers,'covering'genes 1 2 1 0 0 0 0 0 0 0 1 0 0 488 288 1 0 1 783 0.4
losses'<'200kbp,'covering'50'or'more'
markers,'covering'genes,'and'not'>'2'
reported'studies'in'DGV 0 0 0 0 0 0 0 0 0 0 0 0 0 133 56 0 0 1 190 0.1
Sample'number' 1.1 1.2 2.1 2.2 3.1 3.2 4.1 5.1 6.1 7.1 7.2 7.3 8.1 9.1 9.2 10.1 A.1 A.2 Total' Average
gender M M M F M M M F F F F F F M M M F M / /
affected'status'(y/n) y y y y y y y y y y n y y n y y y y / /
gains' 30 20 16 283 96 6 37 20 280 42 110 36 27 1058 191 493 75 405
gains'>500kbp 4 5 2 8 15 1 2 2 16 7 11 6 2 2 2 24 7 10 126 6.5
gains'>'500kbp'covering'genes'and'50'
or'more'markers 4 3 2 6 10 1 0 1 12 5 6 4 1 0 0 21 5 6 87 4.4
gains'>'500kbp'covering'genes,'
covering'50'or'more'markers,'and'not'
>2'reported'studies'in'DGV 0 0 0 1 0 0 0 1 1 1 1 2 0 0 0 0 1 0 8 0.5
gains<'500kbp 26 15 14 273 81 4 32 18 264 34 95 27 25 1056 188 467 67 394 3080 91.3
gains'<'500kbp,'covering'50'or'more'
markers,'covering'genes' 8 2 3 127 20 0 5 1 56 6 28 2 1 385 110 101 14 138 1007 27.4
gains'<'500kbp,'covering'50'or'more'
markers,'covering'genes'and'not'>'2'

















































Sample'number' 1.1 1.2 2.1 2.2 3.1 3.2 4.1 5.1 6.1 7.1 7.2 7.3 8.1 9.1 9.2 10.1 A.1 A.2 Total'
gender M M M F M M M F F F F F F M M M F M /
affected'status'(y/n) y y y y y y y y y y n y y n y y y y /
number'of'LOH'regions 35 107 141 27 121 103 84 57 82 53 110 40 116 200 146 101 42 94 1659
number'of'LOH'regions'at'85%'
confidence 28 60 96 27 88 69 63 39 54 26 73 29 67 101 96 51 40 93 1100
%'of'LOH'in'the'genome 9.56 5.75 5.98 8.58 15.2 8.54 21.3 10.8 6.19 6.72 7.25 7.34 6.72 4.34 18.2 2.53 22.4 36.6 /
number'of'LOH'regions'covering'
genes' 28 54 90 27 83 64 62 38 51 25 68 29 59 87 86 47 40 93 1031
LOH'regions'covering'genes'that'are'
listed'on'OMIM 27 27 54 26 65 45 53 29 36 23 43 25 40 41 49 31 32 89 735
LOH'regions'covering'genes'that'are'
listed'on'OMIM'with'key'words''








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Filter! 7.1! 7.3! Total!
Total!SNV!results!from!exome!
sequencing! 16384$ 16384$ 32768$
Total!SNVs!overlapped!with!16!
LOH!region! 552$ 563$ 1115$







SNV$type 7.1 7.3 Grand$Total
HET 9646 9836 19482
frameshift$deletion 17 19 36
frameshift$insertion 14 10 24
nonframeshift$deletion 42 50 92
nonframeshift$insertion 25 26 51
nonsynonymous$SNV 4919 4940 9859
splicing 926 944 1870
stopgain$SNV 54 57 111
stoploss$SNV 11 10 21
synonymous$SNV 3638 3780 7418
HOM 6738 6548 13286
frameshift$deletion 24 29 53
frameshift$insertion 49 48 97
nonframeshift$deletion 22 20 42
nonframeshift$insertion 27 26 53
nonsynonymous$SNV 3419 3308 6727
splicing 623 626 1249
stopgain$SNV 11 9 20
stoploss$SNV 13 15 28
synonymous$SNV 2550 2467 5017



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































Exon 18 results 
SCORE START END QSIZE IDENTITY CHRO STRAND START END SPAN 
exon 
18 365 1 365 365 100.00% 16 - 3807752 3808116 365 
18_1 196 11 274 369 87.50% 16 - 3807827 3808092 266 
18_2 38 10 48 370 100.00% 16 - 3808052 3808091 40 
18_3 329 1 336 360 99.20% 16 - 3807774 3808111 338 
! 232!
18_4 311 6 325 425 99.10% 16 - 3807780 3808103 324 
18_5 
18_6 325 6 341 359 98.60% 16 - 3807780 3808117 338 
18_7 
18_8 
18_9 322 6 337 497 98.80% 16 - 3807780 3808115 336 
18_10 318 3 330 358 98.80% 16 - 3807778 3808109 332 
18_11 329 2 380 416 98.60% 16 - 3807778 3808331 554 
18_12 313 6 333 360 97.90% 16 - 3807780 3808109 330 


















Exon 19 results 
SCORE START END QSIZE IDENTITY CHRO STRAND START END SPAN 
exon 
19 201 1 201 201 100.00% 16 - 3807242 3807442 201 
19_1 183 2 186 205 98.40% 16 - 3807242 3807425 184 
19_2 181 3 184 203 100.00% 16 - 3807242 3807424 183 
19_3 166 20 185 203 100.00% 16 - 3807277 3807442 166 
19_4 172 9 180 199 100.00% 16 - 3807271 3807442 172 
19_5 
19_6 
19_7 175 5 179 197 100.00% 16 - 3807268 3807442 175 
19_8 144 12 182 199 93.50% 16 - 3807271 3807442 172 
19_9 150 15 190 214 89.60% 16 - 3807273 3807439 167 
19_10 179 1 179 197 100.00% 16 - 3807264 3807442 179 
19_11 172 9 180 199 100.00% 16 - 3807271 3807442 172 
19_12 177 2 178 197 100.00% 16 - 3807266 3807442 177 
! 234!






















  Exon 20 results 
  
 




20 190 1 190 190 100.00% 16 - 3801677 3801866 190 
20_1 183 4 216 349 99.50% 16 - 3801552 3801849 298 
20_2 166 6 173 306 100.00% 16 - 3801677 3801846 170 
20_3 161 9 169 187 100.00% 16 - 3801706 3801866 161 
20_4 161 8 168 185 100.00% 16 - 3801706 3801866 161 
20_5 146 11 172 188 98.10% 16 - 3801705 3801866 162 
20_6 158 10 167 186 100.00% 16 - 3801709 3801866 158 
20_7 154 11 170 188 99.40% 16 - 3801705 3801866 162 
20_8 160 8 167 185 100.00% 16 - 3801707 3801866 160 
20_9 155 8 170 307 95.00% 16 - 3801707 3801866 160 
20_10 151 8 174 193 91.30% 16 - 3801707 3801866 160 
20_11 159 10 170 188 99.40% 16 - 3801706 3801866 161 
20_12 158 8 167 186 99.40% 16 - 3801707 3801866 160 
20_13 146 12 176 192 94.80% 16 - 3801705 3801866 162 
           































  Exon 21 results 
  
 




21 192 1 192 192 100.00% 16 - 3799578 3799769 192 
21_1 166 6 173 192 100.00% 16 - 3799578 3799747 170 
21_2 170 6 175 192 100.00% 16 - 3799578 3799747 170 
21_3 164 2 166 184 100.00% 16 - 3799604 3799769 166 
21_4 157 11 167 278 100.00% 16 - 3799613 3799769 157 
21_5                    
21_6 164 2 166 282 100.00% 16 - 3799604 3799769 166 
21_7 166 2 167 185 100.00% 16 - 3799604 3799769 166 
21_8                    
21_9 131 10 150 310 97.90% 16 - 3799613 3799758 146 
21_10 197 8 291 392 95.40% 16 - 3799611 3808065 8455 
21_11 297 1 334 358 97.50% 16 - 3799602 3808111 8510 
21_12 164 1 168 186 98.90% 16 - 3799602 3799769 168 
21_13 266 4 294 365 98.90% 16 - 3799603 3808065 8463 


























Exon 22 results 
SCORE START END QSIZE IDENTITY CHRO STRAND START END SPAN 
exon 
22 246 1 246 246 100.00% 16 - 3795191 3795436 246 
22_1 229 2 234 386 99.60% 16 - 3795186 3795420 235 
22_2 228 5 234 249 99.60% 16 - 3795186 3795415 230 
22_3 211 17 227 243 100.00% 16 - 3795228 3795438 211 
22_4 219 4 222 237 100.00% 16 - 3795220 3795438 219 
22_5 219 4 222 239 100.00% 16 - 3795220 3795438 219 
22_6 220 1 224 240 98.30% 16 - 3795216 3795438 223 
22_7 218 4 223 240 98.70% 16 - 3795220 3795438 219 
22_8 
22_9 203 9 232 491 94.80% 16 - 3795223 3795438 216 
22_10 223 1 223 241 100.00% 16 - 3795216 3795438 223 
22_11 194 17 230 245 95.20% 16 - 3795228 3795438 211 
22_12 207 8 229 290 94.90% 16 - 3795223 3795438 216 

























  Exon 23 results 
  
 




23 200 1 200 200 100.00% 16 - 3794830 3795029 200 
23_1 173 12 184 203 100.00% 16 - 3794830 3795002 173 
23_2 173 13 185 204 100.00% 16 - 3794830 3795002 173 
23_3 172 1 174 358 98.30% 16 - 3794857 3795029 173 
23_4 170 2 173 381 98.30% 16 - 3794859 3795029 171 
23_5 167 2 171 380 99.50% 16 - 3794859 3795029 171 
23_6 169 1 173 382 98.90% 16 - 3794857 3795029 173 
23_7 169 2 172 368 99.50% 16 - 3794859 3795029 171 
23_8 169 2 171 377 100.00% 16 - 3794859 3795029 171 
23_9 169 2 172 376 99.50% 16 - 3794859 3795029 171 
23_10 166 12 177 194 100.00% 16 - 3794864 3795029 166 
23_11 168 5 174 365 99.50% 16 - 3794860 3795029 170 
23_12 157 16 180 385 95.80% 16 - 3794867 3795029 163 
23_13 167 1 171 368 99.50% 16 - 3794858 3795029 172 


























  Exon 24 results 
  
 




24 274 1 274 274 100.00% 16 - 3790319 3790592 274 
24_1 253 6 264 278 99.30% 16 - 3790306 3790571 266 
24_2 251 3 269 283 97.40% 16 - 3790306 3790574 269 
24_3 242 11 253 270 100.00% 16 - 3790349 3790592 244 
24_4 242 12 254 271 100.00% 16 - 3790349 3790592 244 
24_5 206 14 261 277 92.40% 16 - 3790348 3790592 245 
24_6 244 10 253 272 100.00% 16 - 3790349 3790592 244 
24_7 212 30 258 275 96.60% 16 - 3790363 3790592 230 
24_8 230 13 253 272 99.20% 16 - 3790349 3790592 244 
24_9 244 1 256 274 97.20% 16 - 3790340 3790592 253 
24_10 233 27 259 277 100.00% 16 - 3790360 3790592 233 
24_11 232 30 261 280 100.00% 16 - 3790361 3790592 232 
24_12 234 26 259 277 100.00% 16 - 3790359 3790592 234 






















  Exon 25 results 
  
 




25 258 1 258 258 100.00% 16 - 3789534 3789791 258 
25_1 231 2 235 253 99.60% 16 - 3789534 3789769 236 
25_2 226 10 236 257 100.00% 16 - 3789536 3789764 229 
25_3                     
25_4                     
25_5                     
25_6                     
25_7                     
25_8                     
25_9                     
25_10                     
25_11                     
25_12                     
























  Exon 26 results 
  
 




26 308 1 308 308 100.00% 16 - 3788447 3788754 308 
26_1 284 10 294 314 100.00% 16 - 3788447 3788732 286 
26_2 282 11 294 314 100.00% 16 - 3788447 3788732 286 
26_3  282 1 282 300 100.00% 16 - 3788473 3788754 282 
26_4                282 1 282 301 100.00% 16 - 3788473 3788754 282 
26_5             280 1 281 353 100.00% 16 - 3788443 3788754 312 
26_6            278 4 281 313 100.00% 16 - 3788477 3788754 278 
26_7    276 1 281 303 99.30% 16 - 3788473 3788754 282 
26_8 282 1 282 302 100.00% 16 - 3788473 3788754 282 
26_9     278 4 281 312 100.00% 16 - 3788477 3788754 278 
26_10  288 4 319 354 99.70% 16 - 3788477 3788926 450 
26_11         264 8 286 307 98.20% 16 - 3788476 3788754 279 
26_12     278 4 281 299 100.00% 16 - 3788477 3788754 278 



















 Exon 27 results 
 SCORE START END QSIZE IDENTITY CHRO STRAND START END SPAN 
exon 
27 301 1 301 301 100.00% 16 - 3786577 3786877 301 
27_1 277 7 284 304 100.00% 16 - 3786577 3786855 279 
27_2 281 2 284 304 100.00% 16 - 3786577 3786863 287 
27_3 274 5 278 389 100.00% 16 - 3786604 3786877 274 
27_4 262 22 301 306 96.60% 16 - 3786603 3786876 274 
27_5 227 7 278 295 94.90% 16 - 3786604 3786875 272 
27_6 272 1 277 620 99.30% 16 - 3786600 3786877 278 
27_7 260 1 278 498 96.80% 16 - 3786600 3786877 278 
27_8 274 1 277 463 99.70% 16 - 3786600 3786877 278 
27_9 261 24 288 306 98.10% 16 - 3786615 3786877 263 
27_10 231 17 287 304 96.30% 16 - 3786610 3786877 268 
27_11 177 5 257 279 99.00% 16 - 3786604 3786876 273 
27_12 274 1 278 508 99.30% 16 - 3786600 3786877 278 





















 Exon 28 results 
 SCORE START END QSIZE IDENTITY CHRO STRAND START END SPAN 
exon 
28 327 1 327 327 100.00% 16 - 3786000 3786326 327 
28_1 303 9 313 539 99.10% 16 - 3786000 3786303 304 
28_2 304 9 312 332 100.00% 16 - 3786000 3786303 304 
28_3 300 8 311 333 98.40% 16 - 3786025 3786326 302 
28_4 297 8 304 322 100.00% 16 - 3786030 3786326 297 
28_5 299 10 308 401 100.00% 16 - 3786028 3786326 299 
28_6 304 2 307 437 99.70% 16 - 3786021 3786326 306 
28_7 302 1 305 476 99.70% 16 - 3786021 3786326 306 
28_8 299 7 305 472 100.00% 16 - 3786028 3786326 299 
28_9           
28_10 301 7 307 400 100.00% 16 - 3786026 3786326 301 
28_11 299 6 304 474 100.00% 16 - 3786028 3786326 299 
28_12 300 7 306 435 100.00% 16 - 3786027 3786326 300 





















 Exon 29 results 
 SCORE START END QSIZE IDENTITY CHRO STRAND START END SPAN 
exon 
29 258 1 258 258 100.00% 16 - 3781717 3781974 258 
29_1 234 4 238 482 100.00% 16 - 3781716 3781951 236 
29_2 232 6 241 473 99.20% 16 - 3781716 3781951 236 
29_3 234 2 235 484 100.00% 16 - 3781741 3781974 234 
29_4 245 7 445 494 94.00% 16 - 3781744 3782103 360 
29_5 234 2 235 482 100.00% 16 - 3781741 3781974 234 
29_6 234 1 236 481 99.60% 16 - 3781739 3781974 236 
29_7 233 5 237 470 100.00% 16 - 3781742 3781974 233 
29_8 235 1 238 461 98.40% 16 - 3781739 3781974 236 
29_9 104 7 205 329 84.20% 16 - 3786025 3786220 196 
29_10 231 6 236 469 100.00% 16 - 3781744 3781974 231 
29_11 229 8 236 471 100.00% 16 - 3781746 3781974 229 
29_12 234 1 236 466 99.60% 16 - 3781739 3781974 236 























  Exon 30 results 
  
 




30 397 1 397 397 100.00% 16 - 3781133 3781529 397 
                     
                     
30_3           368 7 374 612 100.00% 16 - 3781162 3781529 368 
30_4      81 5 85 395 100.00% 16 - 3781160 3781240 81 
30_5                      
30_6          373 2 374 583 100.00% 16 - 3781157 3781529 373 
30_7             370 2 375 393 99.00% 16 - 3781157 3781529 373 
30_8                            
30_9             374 1 374 614 100.00% 16 - 3781156 3781529 374 
30_10      372 3 374 546 100.00% 16 - 3781158 3781529 372 
30_11           373 1 373 548 100.00% 16 - 3781157 3781529 373 
30_12      369 7 377 395 99.20% 16 - 3781160 3781529 370 


































            MRC-Holland 
Peak Pattern Evaluation flowchart version MDP-v002; last update 13-01-2012 
 
The references indicate the paragraphs of the One-Tube MLPA Protocol for DNA Detection and Quantification. 
Peak Pattern Evaluation flowchart 
YES 
1. 92 nt control fragment & 
probe amplicons present? 
NO 
YES 
2. Q-fragments: all 4 peaks 
higher  than 1/3 peak of 92 nt 
control fragment? (see §6.3) 
8. All peak signals too low? 




Are MLPA and size standard peaks low and 
broad? 
Primer peak or primer-dimers 
visible (20-60 nt region)? 




1. No or insufficient DNA present 
2. Ligation reaction failed 
1. Check fluorescent dye (see §5.3) 
2. Check size standard peaks. If absent, 
repeat electrophoresis. 
1. PCR failed.  
2. Probemix not added. 
1. Increase capillary injection time or injection voltage (see §5.3). If this doesn’t help:  
2. Repeat capillary electrophoresis and increase amount of PCR product. 
 
7. One or more peak signals 
too high (off-scale)? (See raw 
data checklist.) 
9. Sloping: are peaks of 
longer MLPA probes more 
than 3 times lower than those 
of shorter MLPA probes? 
Does the size 
standard show the 
same sloping?  
1. Formamide, polymer or capillaries may need to be 
replaced. See §5.3. 
2. Check run current: this should be a flat line; if not, check 
separation buffer & injection mixture for air bubbles.  
3. Capillaries overloaded; try using less PCR product. Rerun 




3. D-fragments (88 & 96 nt): 
peak(s) lower  than 40% of 
the 92 nt control fragment? 
(see §6.3) 
Incomplete sample DNA denaturation. Incomplete denaturation most commonly affects CG-
rich areas, such as CpG islands that are often present near exon 1.  
1. Use less sample DNA when possible; this reduces the contaminants which may cause 
denaturation problems. However, be aware to use at least 20 ng. 
2. Make sure your samples are extracted following the guidelines in §3.1. 
3. Perform ethanol precipitation to remove contaminations from the DNA . 
4. In less severe cases, complete DNA denaturation can be accomplished by prolonging the 
5 min 98oC denaturation step (§4.2) to 40 min and/or inclusion of glycerol (5 % v/v end 
concentration) in the 5 µl DNA sample (§3.1). 
NO 
4. Excessive primer-dimer 
formation visible? 
PCR failure. Repeat MLPA experiment. 
6.  Split peaks visible in 
several MLPA probe signals? 
1. The PCR products may have been degraded. Rerun MLPA amplification products using 
high quality mineral oil and formamide. 
2. Denaturation of injection mixture was omitted (see §5.3) 
3. High salt concentration in the injection mixture may cause secondary structure. Make 
sure you do not add more PCR product than is specified in §5.3. 
4. Capillary electrophoresis temperature is too low; see §5.3. 
 
1. Cause 1: Contaminants in the DNA sample; see §3.1. 
2. Cause 2: use of extremely large amounts DNA (old/evaporated/viscous samples). 
3. Cause 3: overloading of capillaries has saturated the fluorescent detection device. See §5.3. 
4. Cause 4: peak broadening due to deteriorated gel or capillaries. See §5.3. 
10. Are there large 
differences in relative peak 
heights between samples that 
don’t make sense? 
YES 
NO 
1. Test the evaporation during the hybridisation reaction (see §6.5). 
2. DNA samples may contain substances that inhibit the PCR reaction; see §3.1. 




5. Apparently random 
decrease of some signals and 
increase of others? 
1. Incomplete hybridisation. (a) check heated lid; (b) check thermocycler performance 
and program settings; (c) check evaporation (see §6.5); (d) repeat sample 
denaturation following §4.2; (d) repeat hybridisation making sure correct quantities 
are used and reagents are properly thawed and mixed (§4.3). 
2. Overloading capillaries in some apparatus (e.g. ABI3700) may result in signals in 
neighbouring capillaries. Make injection mixture as specified in §5.3. 













GO BACK TO § 3.1 SAMPLE TREATMENT; §4 MLPA REACTION – 
DNA DETECTION/QUANTIFICATION OR §5 FRAGMENT 
SEPARATION BY CAPILLARY ELECTROPHORESIS  
 
Replace capillaries or polymer 
Repeat capillary electrophoresis:  
1. Decrease amount of PCR product injected (see §5.3) 
































1 100824&01 3 Gain 8 142450527 144144519 1694 184 0.88 2*genes 138
10120101 4 Gain 8 142478604 142663923 185.32 7 0.93 FLJ43860 42
10120101 4 Gain 8 143308105 143373178 65.073 11 0.91 TSNARE1
1 100824&01 3 Gain 8 144261481 145817594 1556.1 147 0.88 42*genes 170









2 100824&02 3 Gain 8 143272874 143737908 465.03 53 0.88 2*genes
> 10120602 4 Gain 8 143180313 143373178 192.87 14 0.96 NCRNA00051,>TSNARE1 >
2 10120602 3 Gain 8 144874789 145789811 915.02 73 0.89 19*genes 50 >





3 B0921 4 Gain 8 143144004 143391651 247.65 19 0.94 2*genes 6
10120102 3 Gain 8 142450527 144135307 1684.8 179 0.88 NCRNA00051,>TSNARE1 71 >
3 B0921 3 Gain 8 144874789 145817594 942.81 79 0.87 46*genes* 50 >

















9 10121501 1 Loss 2 64673003 65006890 333.89 150 0.864 3*genes 3
10121502 1 Loss 2 64656408 64894680 238.27 148 0.877 AFTPH,>HSPC159,>SERTAD2 3
9 10121501 1 Loss 2 162086299 162297588 211.29 124 0.879 2*genes 5
10121502 1 Loss 2 162173421 162390737 217.32 160 0.892 TBR1,>PSMD14 6
9 10121501 1 Loss 3 142669503 142898579 229.08 121 0.907 3*genes 4
10121502 1 Loss 3 142650099 142883928 233.83 114 0.88 CHST2,>SR140,>PAQR9 2










10121502 3 Gain 10 123262821 123665014 402.19 500 0.935 ATE1,>FGFR2 4
9 10121501 2 Gain Y 8242192 8637819 395.63 126 0.882 2*genes
10121502 2 Gain Y 8469846 8754439 284.59 65 0.852 >TTTY18,>TTTY19
11 10191003 3 Gain 8 144869301 145751248 881.95 71 0.886 44*genes 45 >














11 10191003 4 Gain 8 143308105 143373178 65.073 11 0.956 1*gene














11 10191003 3 Gain 15 20175623 22752399 2576.8 54 0.885 13*genes 269




































2 10120602 3 Gain 1 3213490 3996253 782.763 7906 14#genes:!ARHGEF16,!C1orf174,!CCDC27,!DFFB,!KIAA0495,!KIAA0562,!LOC100133612,!LOC388588,!LRRC47,!MEGF6,!MIR551A,!TP73,!TPRG1L,!WDR8 Loss
























6 10092802 3 Gain 1 3701971 4263677 561.706 3955 4#genes:'C1orf174,DFFB,'KIAA0562,'LRRC47,'LOC100133612 Loss
7 10100602 3 Gain 1 3726325 3996253 269.928 4907 4#genes:'DFFB,'C1orf174,'KIAA0562,'LOC100133612,' Loss
9 10121502 1 Loss 2 242177376 242291694 114.318 977 SEPT2, Loss
9 10121501 1 Loss 2 242248524 242273907 25.383 1493 SEPT2, Loss
9 10121501 1 Loss 15 25664837 25709733 44.896 1448 UBE3A Gain
9 10121501 3 Gain 17 73460617 73702286 241.669 2777 3#genes:'KIAA0195,'CASKIN2,'TSEN54 Loss















10 10120801 3 Gain 2 241072132 241998576 926.444 23754 4#genes:'ANKMY1,'CAPN10,'DUSP28,'RNPEPL1 Loss
































10100601 LOH 9 93095642 102041615
10101102 LOH 9 94820892 100203708
10100601 LOH 11 80332710 109251435
10101102 LOH 11 80341129 88960147
10100601 LOH 12 113273049 126127471
10101102 LOH 12 113740466 126481108
10101102 LOH 16 25991284 31947653
10100601 LOH 16 26280223 31947653
10100601 LOH 16 46540545 78675879
10101102 LOH 16 46540545 79793766
10101102_(Cytogenetics_Array).resultsBforB22Barrays.cy2wg.cychpLOH X 8243429 12240607
10100601_(Cytogenetics_Array).resultsBforB22Barrays.cy2wg.cychpLOH X 8515200 10641757
10100601_(Cytogenetics_Array).resultsBforB22Barrays.cy2wg.cychpLOH X 35953801 39116739
10101102_(Cytogenetics_Array).resultsBforB22Barrays.cy2wg.cychpLOH X 35955810 39657155
10101102_(Cytogenetics_Array).resultsBforB22Barrays.cy2wg.cychpLOH X 62018109 67251413
10100601_(Cytogenetics_Array).resultsBforB22Barrays.cy2wg.cychpLOH X 62269648 67412413
10101102_(Cytogenetics_Array).resultsBforB22Barrays.cy2wg.cychpLOH X 138052949 140892452
10100601_(Cytogenetics_Array).resultsBforB22Barrays.cy2wg.cychpLOH X 138319265 140374229
10101102_(Cytogenetics_Array).resultsBforB22Barrays.cy2wg.cychpLOH X 146613127 150792888
10100601_(Cytogenetics_Array).resultsBforB22Barrays.cy2wg.cychpLOH X 146628589 150379375
227645&Fanconi_anemia(0):NM_000136&(FANCC),&&601309&Basal_cell_carcinoma_somatic(605462):NM_001083607&(PTCH1),&&601309&Basal_cell_nevus_syndrome(109400):NM_000264&(PTCH1),&&601309&HoloprosencephalyK7(610828):NM_001083607&(PTCH1),&&605573&Pseudohermaphroditism_male_with_gynecomastia(264300):NM_000197&(HSD17B3),&&605712&Neuropathy_hereditary_sensory_and_autonomic_type_1(162400):NM_006415&(SPTLC1)&,&&608135&Lumbar_disc_degeneration(603932):NM_017680&(ASPN),&&608135&Osteoarthritis_susceptibility_3(607850):NM_017680&(ASPN),&&611570&FructoseK16Kbidphosphatase_deficiency(229700):NM_000507&(FBP1),&&&&
602365BHaimIMunk_syndrome(245010):NM_148170B(CTSC),BB602365BPapillonILefevre_syndrome(245000):NM_148170B(CTSC),BB
602365BPeriodontitis_juvenile(170650):NM_148170B(CTSC),BB603025BLeukemia_acute_myeloid(601626):NM_007166B(PICALM),BB
603025BLeukemia(0):NM_007166B(PICALM),BB604579BRetinopathy_of_prematurity(133780):NM_012193B(FZD4),BB606933B
Albinism_oculocutaneous_type_IA(203100):NM_000372B(TYR),BB606933B
Skin_hair_eye_pigmentation_3_freckling(601800):NM_000372B(TYR)B,BB606933B
Waardenburg_syndrome_albinism_digenic(103470):NM_000372B(TYR),BB612988BOptic_atrophyI7(612989):NM_032273B
(TMEM126A) ,
142410BDiabetes_mellitus_insulinIdependent(222100):NM_000545B(HNF1A),BB142410BDiabetes_mellitus_noninsulinI
dependent_2(125853):NM_000545B(HNF1A),BB142410BHepatic_adenoma(142330):NM_000545B(HNF1A),BB142410B
MODY_type_III(600496):NM_000545B(HNF1A),BB142410BRenal_cell_carcinoma(144700):NM_000545B(HNF1A),BB163731B
Pyloric_stenosis_infantile_hypertrophic_1_susceptibility_to(179010):NM_000620B(NOS1),BB601406BBIcell_nonI
Hodgkin_lymphoma(0):NM_020993B(BCL7A),BB601620BHoltIOram_syndrome(142900):NM_181486B(TBX5),BB601621BUlnarI
mammary_syndrome(181450):NM_005996B(TBX3),BB606686B
Leukoencephalopathy_with_vanishing_white_matter(603896):NM_001414B(EIF2B1),BB606885BAcylICoA_dehydrogenase_shortI
chain_deficiency_of(201470):NM_000017B(ACADS),BB607444BShwachmanIBodianIDiamond_syndrome(260400):NM_006843B(SDS),BB
608014BNeuropathy_distal_hereditary_motor_type_IIA(158590):NM_014365B(HSPB8),BB609695B
Hawkinsinuria(140350):NM_002150B(HPD),BB609695BTyrosinemia_type_III(276710):NM_002150B(HPD),BB610277B
Immune_dysfunction_with_TIcell_inactivation_due_to_calcium_entry_defect_1(612782):NM_032790B(ORAI1),BB611716B
Cutis_laxa_autosomal_recessive_type_II(219200):NM_012463B(ATP6V0A2),BB611716BWrinkly_skin_syndrome(278250):NM_012463B
(ATP6V0A2),
BB103850BGlycogen_storage_disease_XII(611881):NM_184043B(ALDOA),BB107265B
Antibody_deficiency_due_to_defect_in_CD19___(0):NM_001770B(CD19),BB108730BBrody_myopathy(601003):NM_173201B
(ATP2A1),BB120980BSystemic_lupus_erythematous_association_with_susceptibility_to_6(609939):NM_001145808B(ITGAM),BB
137070BAmyotrophic_lateral_sclerosis_6_autosomal_recessive(608030):NM_001170937B(FUS),BB147781B
AIDS_slow_progression_to(609423):NM_000418B(IL4R),BB147781BAtopy_susceptibility_to(147050):NM_000418B(IL4R),BB157700B
Mitral_valve_prolapse(0):NM_017458B(MVP),BB172471B
Cirrhosis_due_to_liver_phosphorylase_kinase_deficiency___(0):NM_001172432B(PHKG2),BB172471B
Glycogen_storage_disease_IXc(613027):NM_001172432B(PHKG2),BB182381BRenal_glucosuria(233100):NM_003041B(SLC5A2),BB
602389BCombined_oxidative_phosphorylation_deficiency_4(610678):NM_003321B(TUFM),BB605383B
IgE_elevated_level_of(147050):NM_181079B(IL21R),BB605383BLymphoma(0):NM_181079B(IL21R),BB607042BCeroidI
lipofuscinosis_neuronalI3_juvenile(204200):NM_001042432B(CLN3),BB607764B
Cholestasis_progressive_familial_intrahepatic_4(607765):NM_025193B(HSD3B7),BB608547BVitamin_KI
dependent_clotting_factors_combined_deficiency_of_2(607473):NM_206824B(VKORC1),BB608547B
Warfarin_resistance(122700):NM_206824B(VKORC1),B137070B
Amyotrophic_lateral_sclerosis_6_autosomal_recessive(608030):NM_001170634B(FUS),
1
2
3
4
BB104155BProstate_cancer_susceptibility_to(176807):NM_001164766B(ZFHX3),B114019B
Mental_retardation_autosomal_dominant_3(612580):NM_001793B(CDH3),B114021B
Ectodermal_dysplasia_ectrodactyly_and_macular_dystrophy(225280):NM_001793B(CDH3),B114021B
Hypotrichosis_congenital_with_juvenile_macular_dystrophy(601553):NM_001793B(CDH3),B121360B
Myeloid_leukemia_acute(0):NM_022845B(CBFB),B125860BBenzene_toxicity(0):NM_000903B(NQO1),B125860B
Breast_cancer(0):NM_001025434B(NQO1),B125860BLeukemia_postIchemotherapy(0):NM_001025434B(NQO1),B140100B
Anhaptoglobinemia___(0):NM_001126102B(HP),B140100BHypohaptoglobinemia___(0):NM_001126102B(HP),B172490B
Phosphorylase_kinase_deficiency_of_liver_and_muscle_autosomal_recessive(261750):NM_001031835B(PHKB),B188250B
Mitochondrial_DNA_depletion_syndrome_myopathic_form(609560):NM_004614B(TK2),B192090BBreast_cancer(0):NM_004360B
(CDH1),B192090BCleft_lip_with_or_without_cleft_palate_with_gastric_cancer(0):NM_004360B(CDH1),B192090B
Endometrial_carcinoma___(0):NM_004360B(CDH1),B192090BGastric_cancer_familial_diffuse(137215):NM_004360B(CDH1),B192090B
Listeria_monocytogenes(0):NM_004360B(CDH1),B192090BOvarian_carcinoma___(0):NM_004360B(CDH1),B218030B
Apparent_mineralocorticoid_excess(0):NM_000196B(HSD11B2),B218030BHypertension(0):NM_000196B(HSD11B2),B601065BCharcotI
MarieITooth_disease_axonal_type_2N(613287):NM_001605B(AARS),B602218BTownesIBrocks_branchiootorenalI
like_syndrome(107480):NM_002968B(SALL1),B602218BTownesIBrocks_syndrome(107480):NM_002968B(SALL1),B602311B
Leanness(0):NM_001138B(AGRP),B602311BObesity_lateIonset(601665):NM_001138B(AGRP),B602438B
Cataract_lamellar(116800):NM_001538B(HSF4),B602438BCataract_Marner_type(116800):NM_001538B(HSF4),B605131B
Esophageal_squamous_cell_carcinoma(133239):NM_130844B(WWOX),B605956BBlau_syndrome(186580):NM_022162B(NOD2),B
605956BCrohn_disease_susceptibility_to(266600):NM_022162B(NOD2),B605956B
Psoriatic_arthritis_susceptibility_to(607507):NM_022162B(NOD2),B605956BSarcoidosis_earlyIonset(609464):NM_022162B(NOD2),B
606967BFishIeye_disease(136120):NM_000229B(LCAT),B606967BNorum_disease(245900):NM_000229B(LCAT),B606979B
Congenital_disorder_of_glycosylation_type_IIh(611182):NM_032382B(COG8),B607040BEarwax_wet_dry(117800):NM_032583B
(ABCC11),B607456BCirrhosis_North_American_Indian_childhood_type(604901):NM_032830B(CIRH1A),B610937B
Joubert_syndrome_7(611560):NM_001127897B(RPGRIP1L),B610937BMeckel_syndrome_type_5(611561):NM_015272B(RPGRIP1L),B
610966BGrowth_retardation_developMental_delay_coarse_facies_and_early_death(612938):NM_001080432B(FTO),B611026B
Leukodystrophy_dysmyelinating_and_spastic_paraparesis_with_or_without_dystonia(612443):NM_024306B(FA2H),B612051B
Spinocerebellar_ataxia_31(117210):NM_001178020B(BEAN),B613018BTyrosinemia_type_II(277660):NM_000353B(TAT),
5
B300552BOpitz_G_syndrome_type_I(300000):NM_033290B(MID1),BB300808BOcular_albinism_type_I_NettleshipI
Falls_type(300500):NM_000273B(GPR143),BB308700BKallmann_syndrome___(0):NM_000216B(KAL1) ,6
B300481BChronic_granulomatous_disease_XIlinked(306400):NM_000397B(CYBB),BB312610BConeIrod_dystrophyI
1(304020):NM_001034853B(RPGR),BB312610BMacular_degeneration(0):NM_001034853B(RPGR),BB312610BRetinitis_pigmentosa_XI
linked_and_sinorespiratory_infections_with_or_without_deafness(300455):NM_001034853B(RPGR),BB312610BRetinitis_pigmentosaI
3(300029):NM_001034853B(RPGR),BB314850BMcLeod_syndrome___(0):NM_021083B(XK),BB314850B
McLeod_syndrome_with_neuroacanthosis___(0):NM_021083B(XK),
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B300429BHyperekplexia_and_epilepsy(300607):NM_015185B(ARHGEF9)8
300746BThrombophilia_XIlinked_due_to_factor_IX_defect(300807):NM_000133B(F9),B313430BPanhypopituitarism_XI
linked(312000):NM_005634B(SOX3),B300746BWarfarin_sensitivity(122700):NM_000133B(F9),B313430BMental_retardation_XI
linked_with_isolated_growth_hormone_deficiency(300123):NM_005634B(SOX3),B300746BHemophilia_B(306900):NM_000133B(F9)
9
B300120BHypospadias_2_XIlinked(300758):NM_005491B(MAMLD1),BB300415BMyotubular_myopathy_XIlinked(310400):NM_000252B
(MTM1),BB300806BMental_retardation_XIlinked_FRAXE_type(309548):NM_002025B(AFF2),BB309550B
Fragile_X_syndrome(300624):NM_002024B(FMR1),BB309550BFragile_X_tremor_ataxia_syndrome(300623):NM_002024B(FMR1),BB
309900BMucopolysaccharidosis_II___(0):NM_006123B(IDS),
10
